EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 35220

Chapter 35220 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.





Tang, S.D.; Qi, J.; Han, Z.W.; Ming, Z.L., 2003:
Levamlodipine therapy for hypertension after kidney transplantation

Lee, Sang Hee, 1999:
Levantines and Londoners, part II Is the cranial variation in the Levant hominids just too much?

Tiwari, A.; Bhandari, A.; Schlueter, J.; Peabody, J.; Vallancien, G.; Guillonneau, B.; Hinson, C.; Newton, S.; Mueller, D.; Farah, R.; Menon, M., 2001:
Levator Ani Muscle Collar for the continence preservation during conventional and laparoscopic radical prostatectomy

Thor, K.B.; Doherty, P.C.; Bremer, R.E.; Coates, K.; Dolber, P.C., 1999:
Levator ani muscle of the rat Raising awareness of the nomenclature mistake

Delancey, J.; Kearney, R.; Umek, W.; Ashton Miller, J.A., 2003:
Levator ani muscle structure and function in women with prolapse compared to women with normal support

Cervigni, M.; Natale, F.; Fondacaro, L., 2003:
Levator myorraphy

Smith, Edward, 2001:
Level and pattern of DNA sequence variation in the chicken genome

Maciejewski, R.; Kopieniak, M.; Pasternak, K., 2000:
Level changes of oxygen, magnesium, zinc and copper in brain during acute pancreatitis

Berdina, L.; Khusnutdinova, E., 2003:
Level chromosomal variability it the inhabitants of some regions of northeast of republic Bashkortostan as the indicator of ecological condition of region

Benke, S.M.; Sheridan, D., 2003:
Level of CD20 expression and disease activity in chronic lymphocytic leukemia

Gaine, P.C.; Pikosky, M.A.; Martin, W.F.; Bolster, D.R.; Maresh, C.M.; Rodriguez, N.R., 2004:
Level of Dietary Protein Influences Whole Body Protein Turnover Post Exercise in Competitive Endurance Runners

Cassefo, V.; Andrade, D.; Matsudo, V., 2000:
Level of Knowledge about physical activity for the health promotion among students of medicine of the ABC Foundation School of Medicine

Campa, A.; Bansal, S.; Nieto, M.; Nowrouzi, S.; Laird, S.; Baum, M.K., 2004:
Level of Physical Activity Affects Distortion of Body Image

Ríos, A.; Martínez-Alarcón, L.; Ayala-García, M.A.; Sebastián, M.J.; Abdo-Cuza, A.; López-Navas, A.; López-López, A.; Ramírez, E.J.; Muñoz, G.; Camacho, A.; Suárez-López, J.; Castellanos, R.; Rodríguez, J.S.; Martínez, M.A.; Nieto, A.; Ramis, G.; Ramírez, P.; Parrilla, P., 2010:
Level of acceptance of a clinical solid organ xenotransplantation program among personnel in organ transplant-related services in Spanish, Mexican, and Cuban hospital centers

Su, L.J.; Nguyen, S.V.; Nguyen, L.T.; Hinh, P.; Lin, H.Y.; Scribner, R., 2002:
Level of acculturation and the use of alcoholic beverage and tobacco products in Vietnamese American population

Dalton, L.W.; Ely, K.; Page, D.L., 2001:
Level of agreement of twelve community pathologists in evaluating core breast biopsies

Nakahara, S.; Iwashita, T.; Ihara, T.; Nishihara, K.; Abe, R., 1999:
Level of anastomosis does effect anorectal function following low anterior resection for rectal cancer

Rahimkhani, S.; Tran, K.; Wang, Y.; Yao, Z., 2000:
Level of apoC-III mRNA correlates positively to the secretion of triglyceride-rich VLDL from transfected McA-RH7777 cells

Jarosiewicz, B.; Skaggs, W.E., 2002:
Level of arousal during the small irregular activity state in the rat

Konstantinova, N.A.; Matveeva, N.A.; Semenova, E.N.; Konstantinova, N.V., 2000:
Level of cryoglobulins and Leucocytoclastic Vasculitis

Konstantinova, N.A.; Sergeev, U.V.; Grabovskay, V.; Konstantinova, N.V., 2000:
Level of cryoglobulins in serum of patient with atopic dermatitis

Enea, V.; Amico, C.; Pistone, M.; Yakimov, M.M., 2000:
Level of cycloossigenase-2 mRNA expression at various stages of rabbit corneal repair after wound healing treatment

Ploman, F.; Hagglund, L.; Sjoblom, P., 1999:
Level of down-regulation and outcome of IVF/ICSI treatment

Xu, L.; Wang, Y.Xing.; Jonas, J.B., 2010:
Level of education associated with ophthalmic diseases. The Beijing Eye Study

Skolnick, A.J.; Davidson, R.J., 2000:
Level of expectation of reward modulates the eyeblink startle response

Chai, L.; Ma, Y.; Tigges, J.; Kouttab, N.; Maizel, A., 2000:
Level of expression of a novel homeobox gene, Hsal 2, is related to cellular lineage, maturational stage and transformation

Araujo, H.A.; Stoddard, J.; Kariyawasam, K.; Gutierrez, M.; Mulder, A.; Lee, J.H.w; Tongio, M.M.; Schreuder, G.M.T.; Yunis, E.; Ng, J.; Hartzman, R.; Fernandez Vina, M.A., 2002:
Level of expression of multiple HLA-A molecules by flow cytometry with monoclonal antibodies labeled with a single fluorescent dye

Anastasio, P.; Cirillo, M.; Spitali, L.; Frangiosa, A.; Pollastro, R.M.; D.S.nto, N.G., 2001:
Level of hydration and renal function in healthy humans

Akkerhuis, M.; Roth, U.; Hoffmann, J.; Brickl, R.; Simoons, M.L., 2000:
Level of inhibition of platelet aggregation predicts outcome of patients treated with the oral glycoprotein IIb/IIIa receptor antagonist lefradafiban Results from FROST

Roth, U.; Hoffmann, J.; Nehmiz, G.; Akkerhuis, K.M.; Brickl, R.; Baardman, T.; Simoons, M.L., 2000:
Level of inhibition of platelet aggregation predicts outcome of patients treated with the oral glycoprotein IIb/IIIa receptor antagonist lefradafiban Results from the Fibrinogen Receptor Occupancy STudy

Levene, S.; Clancy, T., 2000:
Level of interest among Ashkenazi Jewish women, who have no family history of breast cancer, in genetic testing for breast cancer susceptibility

Hagen, K.B.; Bjorndal, A.; Kvien, T.K., 1999:
Level of mental distress is associated with general practitioner consultation in patients with chronic but not acute or subacute non-inflammatory musculoskeletal pain

Ranganathan, V.K.; Kuykendall, T.; Siemionow, V.; Yue, G.H., 2002:
Level of mental effort determines training induced strength increases

Lacoste, B.; Dovero, S.; Bioulac, B.; Gross, C.E.; Bezard, E., 2002:
Level of mptp induced neuronal death in mice is affected by stress

Bratasz, A.; Goscinski, I.; Galka, P.; Moskala, M.; Lukiewicz, S., 2002 :
Level of nitric oxide and ceruloplasmin in cerebrospinal fluid and blood in head injuries

Leury, B.J.; Dunshea, F.R., 2003:
Level of nutrition and breed can influence basal and beta-adreneregic stimulated fat mobilization in lambs

Zabina, H.Y.; Muravov, O.I., 1999:
Level of physical activity in Russia

Andrade, E.; Matsudo, V.; Matsudo, S.; Andrade, D.; Araujo, T.; Oliveira, L.; Braggion, G.; Raso, V., 2001:
Level of physical activity in adults, including and excluding walking, according to the knowledge of Agita Sao Paulo Program

Michailov, M.I.; Shahgildyan, I.V.; Esaulkova, A.I.; Kuznetsova, A.E.; Romanenko, V.V., 1999:
Level of postvaccination response against hepatitis B among drug users individuals

Beeghly, M.; Martin, B.; Rose Jacobs, R.; Bellinger, D.; Cabral, H.; Frank, D.A., 2003:
Level of prenatal cocaine exposure and child language outcomes at 95 years of age

Frank, D.A.; Beeghly, M.; Rose Jacobs, R.; Knight, W.G.ant; Posner, M., 2000:
Level of prenatal cocaine exposure and school age language development

Frank, D.A.; Jacobs, R.R.se; Beeghly, M.; Augustyn, M.; Bellinger, D.; Cabral, H.; Posner, M., 1999:
Level of prenatal cocaine exposure, center based intervention, and Weschler Pre and Primary School Intelligence Scores at four years of age

Dunjic, R.; Elezovic, I.; Stevanovic, L.H., 2001:
Level of protein S and pregnancy

Chiu, C.H.; Poole, G.; Tardif, M.; Turle, R.; Morcos, R., 2001:
Level of quantification for measuring HCB and PCDD/PCDF in soil

Houansou, J.; Capo Chichi, S., 1999:
Level of recovery of financing costs of a pediatric department Determining factors, approaches to solutions

Pampura, A.; Morozova, O.; Pogomiy, N.; Cheburkin, A.; Svjatkina, O., 2001:
Level of release of IL-4 and IL-5 from peripheral blood lymphocytes in children with atopic dermatitis

Pampura, A.; Morozova, O.; Pogomiy, N.; Cheburkin, A.; Svjatkina, O., 2001:
Level of release of interleukin-4 and interleukin-5 from peripheral blood lymphocytes in children with atopic dermatitis

A.A.mad, A.M.; Sarnak, M.J.; Rand, W.; Gregory, D.; Konstam, M.A.; Salem, D.N.; Levey, A.S., 1999:
Level of renal function as an independent predictor of mortality in patients with left ventricular dysfunction

Rezende, G.; Roque, A.M.rie; Gigou, M.; Dussaix, E.; Challine, D.; Samuel, D.; Feray, C., 2001:
Level of replication and genotypes of hepatitis A virus in fulminant and non-fulminant hepatitis

Perez Padilla, A.; Pellon, R., 2003:
Level of response suppression and amphetamine effects on negatively punished adjunctive drinking

Hasin, D.; Liu, X., 2002:
Level of response to alcohol and DSM-IV alcohol dependence subtypes

Morgan, D.; Hsu, Y.; Stoffel, J.; Dunn, R.L.; Nagel, S.; Fenner, D.; D.L.ncey, J.O.; Mcguire, E.J.; Wei, J.T., 2004:
Level of sexual function is adversely affected by urinary incontinence

Kinikli, G.; Ates, A.; Turgay, M.; Aydogan, N.; Tokgoz, G., 2001:
Level of soluble Fas antigen in patients with allergic rhinitis Its relation to T-cell anergy induced by specific immunotherapy

Haratym Maj, A.E.; Wawrzycka, B.; Luty, S.; Wawrzycki, B.; Cioczek, P., 1999:
Level of soluble L-selectin in premature delivery

Blankenberg, S.; Rupprecht, H.J.ergen; Bickel, C.; Hottkowitz, C.; Lehmann, M., 2000:
Level of soluble vascular cell adhesion molecule and soluble intracelluar adhesion molecule predict future cardiovascular mortality and myocardial infarction in patients with angina pectoris

Korhonen, P.; Kyrylenko, S.; Tapiola, T.; Suuronen, T.; Salminen, A., 1999:
Level of transcriptional repressor protein mSin3A is upregulated during neuronal apoptosis

Blankenberg, S.; Tiret, L.; Poirier, O.; Rupprecht, H.J.; Bickel, C.; Hafner, G.; Meyer, J.; Cambien, F., 2000:
Level of tumour necrosis factor alpha predicts cardiovascular mortality in CAD patients Evaluation of the interaction with the TNFalpha receptor 1 /G-609T polymorphism

Jones, C.A.; Warram, J.H.; Hanna, L.S.; Scott, L.J.; Krolewski, A.S., 2001:
Level of urinary albumin excretion in normoalbuminuric patients with type 1 diabetes as a marker of susceptibility to nephropathy

Matsuo, H.; Zhang, Y.; Morita, E.; Dekio, S., 2003:
Level of vascular endothelial growth factor is elevated in atopic dermatitis

Karlov, V.A.; Romanova, N.A., 2003:
Level rate and prognostic factors of ischemic stroke with hemorrhagic component

Horine, D.A.; Hadimioglu, B.B.; Bruce, R.H.; Noolandi, J.; Elrod, S.A., 2003:
Level sense and control system for biofluid drop ejection devices

Harbeck, N.; Meisner, C.; Prechtl, A.; Untch, M.; Selbmann, H.K.; Sweep, F.; Graeff, H.; Schmitt, M.; Jaenicke, F.; Thomssen, C., 2001:
Level-I evidence for prognostic and predictive impact of uPA and PAI-1 in node-negative breast cancer provided by second scheduled analysis of multicenter Chemo-N0 therapy trial

Thomssen, C.; Harbeck, N.; Meisner, C.; Prechtl, A.; Untch, M.; Lisboa, B.; Selbmann, H.; Schmitt, M.; Jaenicke, F., 2003:
Level-I evidence for prognostic impact of UPA and PAI-1 in node-negative breast cancer patients Ready for use in clinical routine

Toman, Charles R., 1999:
Leveling apparatus for a cutting head of a mower

Van Schaik, C.P.; Pandit, S., 2004:
Leveling coalitions in primate males Toward an explanation of human egalitarianism

Unger, E.; Pereles, F.S.ott, 2000:
Leveling device especially adapted for use in apparatus for performing light beam guided biopsies and the like

Chertow, Glenn M., 2000:
Leveling the paying field in end-stage renal disease

Steinlage, D.L.e; Myers, B.E., 2003:
Leveling wheel structure for a minimum tillage ripper

Diaz, O.; Sun, G.L.u; Salomon, B.; Von Bothmer, R., 2000:
Levels and distribution of allozyme and RAPD variation in populations of Elymus fibrosus Tzvel

Kivela Rajamaki, M.; Maisi, P.; Srinivas, R.; Tervahartiala, T.; Teronen, O.; Husa, V.; Salo, T.; Sorsa, T., 2003:
Levels and molecular forms of MMP-7 and MMP-8 in diseased human peri-implant sulcular fluid

Chen, C'er.; Chen, J.; Zhao, H.; Xie, Q.; Yin, Z.; Ge, L., 2010:
Levels and patterns of polybrominated diphenyl ethers in children's plasma from Dalian, China

Ricklund,N.; Kierkegaard,A.; McLachlan,M.S., 2010:
Levels and potential sources of decabromodiphenyl ethane and decabromodiphenyl ether in lake and marine sediments in Sweden

Bjork, T.; Ulmert, D.; Becker, C.; Nilsson, J.A.; Berglund, G.; Lilja, H., 2002:
Levels and ratios of PSA-forms and hK2 in plasma discriminate men with prostate cancer from men without cancer up to 20 years before diagnosis

Hayward, S.J.; Gouin, T.; Wania, F., 2010:
Levels and seasonal variability of pesticides in the rural atmosphere of Southern Ontario

Hellou, J.; King, T.; Leonard, J.; Milligan, T.G.; Stellar, S.; Yeats, P.; Zitko, V., 2000:
Levels and source apportionment of polycyclic aromatic hydrocarbons and sulfur heterocycles in sediments and mussels

Lebeuf, M.; Gouteux, B.; Measures, L.; Trottier, S., 2004:
Levels and temporal trends of polyhrominated diphenyl ethers in Beluga whales from the St Lawrence estuary, Canada

You, D.; Wardlaw, T.; Salama, P.; Jones, G., 2010:
Levels and trends in under-5 mortality, 1990-2008

Shoskes, D.A.; Lapierre, C.; Zeitlin, S., 2003:
Levels of 16S bacterial DNA in semen by real time PCR do not correlate with clinical diagnosis or treatment response in category III chronic prostatitis

Bezman, Y.; Rouseff, R.L.; Naim, M., 2001:
Levels of 2-methyl-3-furanthiol and methional and relative levels of -beta-damascenone in the headspace of fresh, pasteurized, and stored orange juice as determined by GC-olfactometry

Xu, Y.; Hingtgen, J.N.; Zhou, F.C., 2000:
Levels of 5-HT and 5-HIAA in tissues of pregnant rats and their fetuses

Chen, G.; Heilbrun, L.K.; Atkins, M.; Covington, C.; Djuric, Z., 2002:
Levels of 8-isoprostanes in breast nipple fluids decline with time in women following low-fat diets

Gupta, S.K.; Chalam, K.V.; Vinjamaram, S.; Pakalinis, V.A., 2002:
Levels of Alpha-V beta-3 Integrin on Proliferating Endothelial Cells of CNV

Mikolajczyk, S.D.; Millar, L.S.; Wang, T.J.; Wolfert, R.L.; Rittenhouse, H.J., 1999:
Levels of B-PSA, a specific form of Free PSA, are higher in BPH-associated transition zone than in either benign or cancerous peripheral zone tissue

Buffon, A.; Liuzzo, G.; Biasucci, L.M.; Ramazzotti, V.; Rigattieri, S.; Comerci, G.; Crea, F.; Maseri, A., 1999:
Levels of C-reactive protein before coronary angioplasty predict outcome in both stable and unstable angina patients

Benboubker, L.; Watier, H.; Domenech, J.; Carion, A.; Cartron, G.; Georget, M.T.; Herault, O.; Desbois, I.; Delain, M.; Bardos, P.; Colombat, P.; Binet, C., 2000:
Levels of CD34+ progenitor cells mobilized into peripheral blood are associated with SDF1 gene variants

Feliu, M.S.; Vidueiros, S.M.; Godoy, M.F.; Pallaro, A.N.; Fernandez, I.; Lopez, C.; Pineiro, A.; Strasnoy, I.; Barbeito, S.; Major, M.; Alvarez, R.; Ramos, O.; Slobodianik, N.H., 2004:
Levels of Copper and Zinc in pediatric critical patients

L.J.ng Chen; Xie Zhao Xia; Tan D.R.n; E.A., 2002:
Levels of EPO in the serum of patients with acute leukemia

Ramakrishna, G.; Fornwald, L.W.; Anderson, L.W., 1999:
Levels of GTP-bound K-ras p21 in transformed mouse lung epithelial cells and in mouse lung tumors

Wolf, L.A.; Reed, G.F.; Buggage, R.R.; Nussenblatt, R.B.; Chan, C.C., 2002:
Levels of IL-10 and IL-6 in the Vitreous are Helpful for Differential Diagnosis of Primary Intraocular Lymphoma and Ocular Inflammation

Trezkova, V.; Nedzvedz, G.; Matusevich, L.; Shcharbina, N.Y., 2003:
Levels of IgG and TNF-alpha in cerebrospinal fluid of patients with Herpes zoster

Domenech, J.; Carion, A.; Benboubker, L.; Herault, O.; Roingeard, F.; Degenne, M.; Cartron, G.; Desbois, I.; Colombat, P.; Binet, C., 2002:
Levels of MMP-9 but not SDF-1 after G-CSF mobilization are correlated with mobilizing capacity

A.H.llaq, R.A.; Yasuda, R.P.; Wolfe, B.B., 1999:
Levels of NMDA NR1 cassettes in the post-synaptic densities of rat cortex and cerebellum

Chang, P.; Soliman, A.; Li, D., 2001:
Levels of O6-methylguanine and O6-methylguanine methyl transferase in colorectal tumors

Skaug, M.A., 2003:
Levels of Ochratoxin A and IGG against conidia from Penicillium verrucosum in blood samples from healthy farm workers and blood donors

Paumgartten, F.J.R.; Cruz, C.M.; Chahoud, I.; Palavinskas, R.; Mathar, W., 2000:
Levels of PCDD/Fs, PCBs and organochlorine pesticide residues in a pooled sample of mothers milk from Rio de Janeiro, Brazil

Wang, R.Y.; Needham, L.L., 2003:
Levels of Polychlorinated dibenzo-p-dioxins , Polychlorinated dibenzofurans , and Polychlorinated biphenyls in human milk at two US locations

Andersen, N.; Poulsen, S.; Heickendorff, L.; Knudsen, S.; Mogensen, C., 2003:
Levels of Pro-BNP-NT in relation to diastolic function and left ventricular geometry in normoalbuminuric patients with type 2 diabetes

Togawa, A.; Yamamoto, T.; Suzuki, H.; Fukasawa, H.; Fujigaki, Y.; Hishida, A., 2001 :
Levels of Smad 2, 3, 4 and 7 in glomeruli from rats with anti-thymocyte serum nephritis

Dreden, P.V.n; Auvrignon, A.; Fontaine, S.; Leverger, G.; Deschamps, A.; Favier, R., 2002:
Levels of TFPI in Newborns and Infants with Leukaemia

Kawinski, E.; Kumar, B.N.; Huben, R.; Mahoney, M.C.; Phadke, S.; Ambrus, J.L.; Nair, M.P.N.; Schwartz, S.A.; Cherrin, C.; Chadha, K.C., 2003:
Levels of VEGF, IL-8, and TGF-b in patients with prostate cancer and in normal individuals

Sonnet, E.; Gibassier, J.; Derrien, C.; Massart, C.; Allannic, H.; Maugendre, D., 1999:
Levels of adhesion molecules in new onset type 1 diabetic patients

Sanicanin, Z.; Lolic, B.; Uletilovic, S., 2001:
Levels of alpha-1-proteinase inhibitor and total immunoglobulin E in the serum of children passive smokers

Elhassan, Y.M.; Tasca, R.J.; Westhusin, M.E., 1999:
Levels of amino acids in bovine oviductal and uterine fluids in comparison to levels available in a culture medium supplemented with commercial stocks

Harris, L.R.; Beykirch, K.; Fetter, M., 2003:
Levels of analysis of the vestibulo-ocular reflex A postmodern approach

Niven, P.C.; Madjor, D.; Samson, A.; Lee, S.R.; Green, G.A.; Gwo, J.R.; Fong, T.L.ng, 1999:
Levels of antibodies to HCV structural antigens correlate with serum HCV RNA levels in chronic hepatitis C patients undergoing interferon therapy

Galarreta, D.J.; Corrales, R.M.; Herreras, J.M.; Gonzalez, M.J.; Arranz, I.; Saez, V.; Mayo, A.; Cisneros, A.B.; Calonge, M.; Chaves, F.J., 2003:
Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers

Koc, M.; Taysi, S., 2003:
Levels of antioxidant proteins in serum of patients with cancer during radiotherapy

Gyorffy, E.; Gyori, Z.; Soltesz, I.; Kostic, S.; Csekeo, A.; Minarovits, J.; Schoket, B., 2002:
Levels of aromatic DNA adducts in tumorous and normal tissues from lung cancer patients

Gutierrez Bustillo, M.; Saenz Lain, C., 2000:
Levels of atmospheric pollen of Olea europaea L in Madrid and Aranjuez between 1994 and 1997

Thomas, M.D.; Kalra, P.R.; Jones, A.; Wright, M.; Struthers, A.D.; More, R.S., 2001:
Levels of atrial natriuretic peptide predict short term success of DC cardioversion for persistent atrial fibrillation

Ioannidis, I.; Komitopoulos, N.; Tsaglis, H.; Giakoumaki, A.; Amantou, A.; Sotiropoulou, G.; Varsamis, E.; Katsilambros, N., 1999:
Levels of autoantibodies against oxidized LDL in diabetic subjects are higher when macroangiopathy is present

Lahey, E.C.; Van Den Waardenburg, M.; Blaauwgeers, H.G.T.; D.V.nte, J.; Kessels, A.G.H.; Liem, A.T.A.; Steinbusch, H.; Hendrikse, F., 2001:
Levels of basic fibroblast growth factor , gluatamate synthetase and interleukin-6 in subretinal fluid from patients with retinal detachment

Bairey, O.; Zimra, Y.; Rabizadeh, E.; Shaklai, M., 1999:
Levels of basic fibroblast growth factor in sera of patients with lymphoproliferative diseases

Holman, R.R.; Kahn, S.E.; Heise, M.A.; Porter, L.E.; Freed, M.I.; The Adopt Study Group, 2003:
Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study

Watanabe, Y.; Kimura, S.; Ban Nai, T.; Sahoo, S.K.mar; Kofuji, H.; Yonehara, H., 2000:
Levels of beta-ray emitters in plant samples collected around the uranium conversion facility after the criticality accident in Tokai-mura

Essalam, M.S.f; Donnard, M.; Trimoreau, F.; Allegraud, A.; Autofage, F.; Turlure, P.; Bordessoule, D.; Feuillard, J., 2003:
Levels of blood circulating CD34+ progenitors are correlated with endogenous erythroid colony formation from bone marrow mononuclear cells

Kingdom, Frederick A.A., 2003:
Levels of brightness perception

Vincent Salomon, A.; Zafrani, B.; Nicolas, A.; Couturier, J.; Sastre Garau, X., 2001:
Levels of c-erbB-2 expression similar in primary and secondary breast carcinomas

Wiig, O.; Renzoni, A.; Gjertz, I., 1999:
Levels of cadmium and mercury in the hair of Atlantic walruses from Svalbard, Norway

Adeniyi, A.A.; Idowu, A.B.; Okedeyi, O.O., 2003:
Levels of cadmium, chromium and lead in dumpsites soil, earthworm , housefly and dragon fly

Robillard, S.; Beauchamp, G.; Paillard, G.; Belanger, D., 2002:
Levels of cadmium, lead, mercury and 137caesium in caribou tissues from northern Quebec

Vega,C.M.; Siciliano,S.; Barrocas,P.R.G.; Hacon,S.S.; Campos,R.C.; Jacob,S.doC.; Ott,P.H., 2010:
Levels of cadmium, mercury, and lead in Magellanic penguins stranded on the Brazilian coast

Bueno, M.S.; Cunha, E.A.; Santos, L.E.; Vitti, D.M.S.S., 1999:
Levels of calcium for growing kids Calcium excretion and phosphorus true absorption

Burke, R.T.; Kiessling, L.S., 2000:
Levels of care Primary care residents self-assessment of ability to care for children with chronic health conditions

Russo, V.; Howard, L., 2001:
Levels of carotenoids in fruit from pungent and non-pungent peppers grown in the greenhouse and field

Faderl, S.; Thall, P.F.; Kantarjian, H.M.; Beran, M.; Kornblau, S.; Talpaz, M.; Thomas, D.; Pierce, S.; Harris, D.; Van, Q.; Estrov, Z., 1999:
Levels of caspase 2 and caspase 3 as predictors for complete remission and survival in adults with acute lymphoblastic leukemia

Kerokoski, P.; Puolivali, J.; Roschier, M.; Suuronen, T.; Salminen, A.; Soininen, H.; Pirttila, T., 2000:
Levels of cdk5 and p35 are reduced in neuronal apoptosis and in APP+PS-1 transgenic mice

Feliu, M.S.; Alvarez, R.; Lopez, C.M.; Ramos, O.; Slobodianik, N.H., 2004:
Levels of ceruloplasmine and serum copper in pediatric critical patients Preliminary study

Eish, M.Y.Z.A.oul; Wells, M.J.M.; Stearman, G.K.m; Ensor, D.D.; Hindi, M.M., 2000:
Levels of cesium-137 in relation to land use patterns

Cranmer, M.F.; Louie, S.C.; Cranmer, K.S.; Cranmer, J.M., 1999:
Levels of chlorinated hydrocarbon pesticides in the urban population of Arkansas

Polin, M.R.; Costanzo, J.P.; Yi, S.X.; Lee, R.E., 2003:
Levels of cholesterol in blood and plasma membrane in response to environmental stress in the hatchling painted turtle

Edberg, J.C.; Zhou, T.; Aksu, K.; Kimberly, R.P.; Hoffman, G.S.; S.C.air, E.W.; Merkel, P.A.; Spiera, R.; Dellaripa, P.F.; Regan, M.J.; Allen, N.L.; Clark, T.; Stone, J.H., 2003:
Levels of circulating B lymphocyte stimulator are elevated in patients with Wegeners granulomatosis

Rossig, L.; Kamper, U.; Fichtlscherer, S.; Zeiher, A.M.; Dimmeler, S., 2002:
Levels of circulating apoptotic endothelial cells reflect disease activity in patients with coronary artery disease

Benboubker, L.; Roingeard, F.; Herault, O.; Delam, M.; Degenne, M.; Desbois, I.; Cartron, G.; Colombat, P.; Binet, C.; Domenech, J., 2001:
Levels of circulating progenitor cells assessed for 24 hours following injection of glycosylated or non-glycosylated G-CSF to determine optimal time of graft harvesting

Sandri, M.T.; Zorzino, L.; Bosari, S.; Colleoni, M.; Goldhirsch, A.; Rocca, A.; Viale, G., 1999:
Levels of circulating vascular endothelial growth factor in monitoring the response to anti-angiogenetic therapy in breast cancer

Callas, P.W.; Long, G.L.; Bovill, E.G.; Rosendaal, F.R., 2000:
Levels of clotting factors, including risk factors for venous thrombosis, cluster as discrete groups

Papanikolaou, A.; Wang, Q.S.; Mulherkar, R.; Rosenberg, D.W., 1999:
Levels of colonic non-pancreatic secretory phospholipase A2 are inversely related to azoxymethane-induced tumor susceptibility in mice

Ivanov, G.I., 2003:
Levels of concentration of pollutants in bottom marine environment of the Shotkman gas field

Watkins, R.; Boulton, R.B., 1999:
Levels of copigmentation cofactors in grape skins and wines

Arellano, J.M.; Ortiz, J.B.; D.S.lva, D.C.peta; D.C.nales, M.L.G.nzalez; Sarasquete, C.; Blasco, J., 1999:
Levels of copper, zinc, manganese and iron in two fish species from salt marshes of Cadiz Bay

Schmidt, F.; Hoffmann, J.H.; Donnelly, D., 1999:
Levels of damage caused by Melanterius servulus Pascoe , a seed-feeding weevil introduced into South Africa for biological control of Paraserianates lophantha

Goldstein, N.S., 2002:
Levels of decreased E-cadherin membrane expression for a dyshesive growth pattern and lobular carcinoma-type systemic metastases are different

Khalil, S.A.H.; A.S.areef, A.H., 2000:
Levels of degradation products during storage of rifampicin dosage forms

Josipovic, B., 1999:
Levels of dehydroepiandrosterone sulfate in female patients with early stage of rheumatoid arthritis

Sennvik, K.; Wahlund, L.O.; Winblad, B.; Fastbom, J.; Benedikz, E., 1999:
Levels of differentially cleaved beta-amyloid protein precursor in the cerebrospinal fluid of Alzheimer patients and healthy controls

Koh, P.O.; Lezcano, N.; Bergson, C.; Goldman Rakic, P.S.; Koh, P.O.; Lidow, M.S., 2001:
Levels of dopamine receptor associated proteins, filamin and calcyon, in the prefrontal cortex of schizophrenic and depressive patients

Bradshaw, H.B.; Krey, J.F.; Walker, M., 2003:
Levels of endocannabinoids and related lipid mediators in the female rat reproductive tract change as a function of estrous cycle

Kitakawa, A.Y.; Hamasaki, R.M.; Mercier, H., 2003:
Levels of endogenous free amino acids during induction phase of shoot organogenesis in leaves of pineapple cultured in vitro

Bilodeau, J.F.ancois; Sirard, M.A.dre, 2001:
Levels of enzymatic antioxidant defenses are modulated in bovine oviductal fluid during the estrous cycle

Valik, D.; Nekulova, M.; Vondracek, V.; Jandakova, E.; Petrakova, K., 2002:
Levels of estrogen receptor in breast cancer tissue can be significantly underestimated in specimens taken by core needle biopsy

Meduri, G.U., 1999:
Levels of evidence for the pharmacologic effectiveness of prolonged methylprednisolone treatment in unresolving ARDS

Yoshinaga Itano, Christine, 2004:
Levels of evidence universal newborn hearing screening and early hearing detection and intervention systems

Lange, Carlos E., 2003:
Levels of experimental and natural sporulation of Nosema locustae in grasshopper and locust species of Argentina

Davies, G.; Cunnick, G.H.; Mansel, R.E.; Mason, M.D.; Jiang, W.G., 2002:
Levels of expression of tumor endothelial markers and their correlation with prognosis in patients with breast cancer

Ciftci,H.; Ozkaya,A.; Cevrimli,B.S.; Bakoglu,A., 2010:
Levels of fat-soluble vitamins in some foods

Owens, D.J.; Kneebone, J.W.; Duncan, B.D., 1999:
Levels of fibroblast growth factor Basic and vascular endothelial growth factor in pediatric patients with cyanotic heart disease

Rashev, P.; Kopchaliiska, D.; Georgieva, R., 2001:
Levels of fibronectin in fetal fluids and blood plasma during pregnancy of pigs

Abadi, R.V.; Clement, R.; Gowen, E., 2003:
Levels of fixation

Liang, X.; Shen, D.; Garfield, S.; Gottesman, M.M., 2002:
Levels of gamma-catenin are decreased in cisplatin-resistant cells

Schneider, K.A.; Chittenden, A.B.; Digianni, L.M.; Patenaude, A.F.; Gelman, R.; Garber, J.E., 2001:
Levels of genetics knowledge and distress A comparison of cancer survivors and unaffected women in a BRCA1/2 testing program

Knee, A.M.; Krisher, R.L., 2000:
Levels of glycolytic activity in in vitro matured bovine oocytes are predictive of cleavage potential

Trifonov, I.R.; Katrukha, A.H.; Yavelov, I.S.; Averkov, O.V.; Kuznetsov, B.V.; Gratsiansky, N.A., 2000:
Levels of heart fatty acid binding protein and cardiac troponin I early in the course of acute myocardial infarction in patients receiving thrombolytic therapy

Paz Gonzalez, A.; Taboada Castro, T.; Taboada Castro, M., 2000:
Levels of heavy metals in agricultural soils of Northwest Spain

Zhou, Y.; Franck, J.; Spangler, R.; Maggos, C.E.; Ho, A.; Kreek, M.J., 2000:
Levels of hypothalamic POMC and anterior pituitary CRF1 receptor mRNA are reduced after acute binge alcohol and return to normal levels after chronic daily alcohol administration

Lees, N.P.ter; Hall, N.; Harrison, K.L.; Margison, G.P.; Povey, A.C., 2000:
Levels of immunoreactive O6-alkylguanine DNA-alkyltransferase in normal colorectal mucosa associated with adenomatous polyps and matched controls

Varga, L.; Kiss, K.; Fust, G.; Nagy, K., 2000:
Levels of in vivo generated complement activation products and C1 inhibitor in a C1 inh concentrate-treated patient with capillary leak syndrome following bone marrow transplantation

Vickerman, D.; Michels, A.; Burrowes, P.A., 1999:
Levels of infection of migrating monarch butterflies, Danaus plexippus by the parasite Ophryocystis elektroscirrha , and evidence of a new mode of spore transmission between adults

Fujimoto, T.; Uramoto, H.; Shiiki, H.; Nakamura, S.; Iwano, M., 2001:
Levels of interleukin 18 in the sera and urine of patients with IgA nephropathy

Uramoto, H.; Fujimoto, T.; Maekawa, K.; Shiiki, H.; Okamura, H.; Nakamura, S.; Dohi, K., 2000 :
Levels of interleukin 18 in the sera of patients with lupus nephritis

Radica, D.; Mitrovic, M.; Rakic, R.; Antic, A., 1999:
Levels of intracellular magnesium in preterm labor

Blomberg, B.; Sherwood, E.; Kamm, K.; Young, A.; Ladha, A.; Perez, M.; Lonberg, N.; Karasuyama, H.; Riley, R., 1999:
Levels of lambda 5 may regulate pre-B lymphocyte development in young as well as aged mice

Prabu,P.C., 2010:
Levels of lead in urban soils from Addis Ababa and Nazerath cities of Ethiopia

Crespo, J.; Amado, J.A.tonio; Garcia Unzeta, M.T.resa; Almohalla, C.; Garcia Pajares, F.; Castro, B.; Pons Romero, F., 1999:
Levels of leptin in hepatitis C and its relationship with hepatic fibrosis

Basu, S.; Hayashi, M.; Ritsuko, N.; Kobayashi, K.; Takeda, S.; Ishihara, O., 2002:
Levels of lipid peroxidation products and anti-oxidants in preclampsia and normal pregnancy

Little, R.E.; Gladen, B.C., 1999:
Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature

Danilchik, V.S.; Spivak, L.V.; Zubovskaya, Y.T.; Kolb, V.G.; Kostin, G.M.; Korosteleva, L.B.; Yurago, T.M., 2001:
Levels of lipids peroxidation and antioxidant protection in newborns and their mothers living in radionuclide contaminated regions of Republic of Belarus

Everett, S.M.; Neville, P.; Singh, R.; Leuratti, C.; White, K.; Schorah, C.; Forman, D.; Shuker, D.; Axon, A., 2000:
Levels of malondialdehyde-DNA adducts in gastric mucosa are unaffected by Helicobacter pylori infection

Piro, M.; Liuzzo, G.; Angiolillo, D.J.seph; Rizzello, V.; Colizzi, C.; Raimondi, F.; Ginnetti, F.; Biasucci, L.M.rzio, 2001 :
Levels of mannan binding lectin, an innate immune system plasmaprotein, are elevated in patients with ischemic heart disease and correlate with C-Reactive protein levels

Chen, C.; Isabelle, L.M.; Pickworth, W.B.; Pankow, J.F., 2010:
Levels of mint and wintergreen flavorants: smokeless tobacco products vs. confectionery products

Anstis, Stuart, 2003:
Levels of motion perception

Beloglazov, V.A.; Gordienko, A.I.; Bakova, A.A.; Znamenskaya, L.N.; Rozovenko, A.V.; D.B.ske, L.M., 2003:
Levels of natural antibodies to endotoxin in bronchial asthma patients undergoing allergen specific immunotherapy

Beloglazov, V.A.; Gordienko, A.I.; Bakova, A.A.; Babanin, A.A.; Dubuske, L.M., 2002:
Levels of natural antibodies to endotoxin in healthy individuals in Crimea

Stone, T.W.; Forrest, C.M.; Kennedy, A.; Darlington, L.G.; Gould, S.R., 2002:
Levels of neuroactive purines, kynurenines and lipid peroxidation products in patients with inflammatory bowel disease

Boulanger, L.M.; Colaco, N.A.; Shatz, C.J., 2003:
Levels of neuronal class I MHC determine the threshold for bidirectional synaptic plasticity

Navarro-Gonzálvez, J.A.; Arenas, J.; Díez Lobato, R.; Gómez, P.; Rodríguez-Arias, C.A., 2000:
Levels of nitric oxide are markedly increased in cerebrospinal fluid from patients with severe head injury

Gallai, B.; Mazzotta, G.; Coppola, F.; Floridi, F.; Sarchielli, P., 2003:
Levels of nitrites and sensory neuropeptides in salivary secretions of young migraine patients during attacks

Shishehbor, M.H.; Aviles, R.J.; Brennan, M.L.ise; Fu, X.; Penn, M.S.; Sprecher, D.L.; Gokce, N.; Keaney, J.F.J.; Vita, J.A.; Hazen, S.L., 2003:
Levels of nitrotyrosine, an inflammatory marker generated by nitric oxide derived oxidants, is associated with risk of coronary artery disease

Vetter, W.; Weichbrodt, M.; Scholz, E.; Luckas, B.; Oelschlaeger, H., 1999:
Levels of organochlorines in blubber of South African fur seals from Cape Cross/Namibia

Seljeflot, I.; Aase, O.; Eid, H.; Lyberg, T.; Arnesen, H., 2002:
Levels of oxidative stress are associated with C-reactive protein levels in patients with stable and unstable angina

Mertens, A.; Muls, E.; Vansant, G.; Collen, D.; Holvoet, P., 2000:
Levels of oxidized low density lipoproteins are increased in obese patients

Djedjibegovic,J.; Marjanovic,A.; Sober,M.; Skrbo,A.; Sinanovic,K.; Larssen,T.; Grung,M.; Fjeld,E.; Rognerud,S., 2010:
Levels of persistent organic pollutants in the Neretva River determined by deployment of semipermeable membrane devices

Ruscetti, F.; Cao, Z.; Flanders, K.; Bertolette, D.; Wurthner, J.; Parks, W.T.; Letterio, J.J.; Roberts, A.B., 2002:
Levels of phospho-Smad2/3 are regulators of the commitment to monocytic and granulocytic differentiation of HL-60 cells by TGF-beta, vitamin D3 and retinoic acid

Sterin, M.; Cohen, J.S.; Mardor, Y.; Berman, E.; Ringel, I., 2000:
Levels of phospholipid metabolites in breast cancer cells treated with anti-mitotic drugs A 31P MRS study

Hodt, C.; Hausken, V.; Klasson Heggebo, L.; Fredriksen, P.M., 2003:
Levels of physical activity in 9- to 12-year old children in Norway Do they fulfill the recommendations?

Nilsson, A.; Ekelund, U.; Yngve, A.; Sjostrom, M., 2002:
Levels of physical activity in children and adolescents in comparison with existing recommendations for health

Grypioti, A.D.; Papadimas, G.K.; Fragopoulou, E.; Basagiannis, A.C.; Demopoulos, C.A.; Papadopoulou Daifoti, Z.; Mykoniatis, M.G., 2004:
Levels of platelet-activating factor during liver regeneration after paracetamol-induced liver injury

Yatoh, S.; Mizutani, M.; Kawakami, Y.; Okuda, Y.; Kozawa, T.; Matsuo, K.; Suzuki, H.; Yamashita, K., 1999:
Levels of platelet-derived growth factor and vascular endothelial growth factor are elevated in vitreous fluids from patients with proliferative diabetic retinopathy

Corbella Tena, R.; Garcia Montelongo, F., 1999:
Levels of polychlorinated biphenyls in Patella piperata from the coast of Fuerteventura

Myers, S.R.; Cunningham, C.; Wright, T.; Weeks, J., 2003:
Levels of polycyclic aromatic hydrocarbons in amniotic fluid samples from smokers and nonsmokers

Mohamed, M.A.; Dean, C.; Cunningham Rundles, S.; Nesin, M., 2002:
Levels of pro-inflammatory cytokines produced in vitro are pathogen-dependent

Ross, Helen E., 2003:
Levels of processing in the size-distance paradox

Panagopoulos, G.; Schianodicola, J., 1999:
Levels of professional satisfaction among academic and non-academic anesthesiologists

Taal, M.W.; Rennke, H.G.; Troy, J.L.; Gurnani, A.; Brenner, B.M.; Mackenzie, H.S., 1999:
Levels of proinflammatory cytokine gene expression predict the progression of renal injury in 5/6 nephrectomized rats treated with inhibitors of the renin angiotensin system

Foglesong, P.D.; D'andrea, M.R., 1999:
Levels of protein and mRNA of DNA topoisomerase IIalpha in human tumors

Prathalingam, N.S.; Scaife, J.R.; Heasman, L.; Parker, J.R.; Chapple, D.G.; Lomax, M.A., 2001:
Levels of protein intake in young restricted steers do not affect myofibrillar protein degradation

Yen, H.C.uan; Chang, H.M.ng; Yang, Y.Y.; Majima, H.; Lee, C.P.i, 2003:
Levels of reactive oxygen species and primary antioxidant enzymes in WI38 versus transformed WI38 cells treated with bleomycin

Marelli, D.C.; Arnold, W.S.; Bray, C., 1999:
Levels of recruitment and adult abundance in a collapsed population of bay scallops in Florida

Ratner, S.; Piechocki, M.P.; Lerman, S.P., 1999:
Levels of regulation of lymphocyte appendage formation and polarity

Pomarico, L.; de Souza, I.Pomarico.Ribeiro.; Castro, Gória.Fernanda.Barbosa.de.Araújo.; Teles, R.Palmier.; Luiz, R.Raggio.; Maia, L.Cople., 2010:
Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: a systematic review

Werner, G.T., 1999:
Levels of selenium in the skin of patients with chronic lymphedema

Hamer, P.J.; Burrell, M.; Morris, L.D.; Carney, W.P., 2002:
Levels of serum EGFr in cancer patients

Zozulinska, D.; Sobieska, M.; Wiktorowicz, K.; Wierusz Wysocka, B., 1999:
Levels of serum cell adhesion molecules in Type I diabetic patients with microangiopathy

Yan Guan Ming; Liu J.Y.ng; Yang Hong Zhong, 2000:
Levels of serum sTNFR in patients with lung cancer

Dolara, P.; Caderni, G.; Palli, D.; Russo, A.; Morozzi, G.; Cresci, A., 2001:
Levels of short chain fatty acids and bile acids in fecal water and colon mucosa proliferation in humans

Houghton-Triviño, N.; Salgado, D.M.; Rodríguez, J.A.; Bosch, I.; Castellanos, J.E., 2010:
Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation

Blankenberg, S.; Rupprecht, H.J.; Bickel, C.; Schlitt, A.; Lotz, J.; Rippin, G.; Meyer, J., 2000:
Levels of soluble vascular cell adhesion molecule and soluble intracellular adhesion molecule predict future cardiovascular events in patients with documented coronary artery disease

Booij, K.; Zegers, B.N.; Boon, J.P., 2002:
Levels of some polybrominated diphenyl ether flame retardants along the Dutch coast as derived from their accumulation in SPMDs and blue mussels

Rychlik, I.; Tesar, V.; Jirsa, M.; Pacltova, M.; Dudkova, L., 1999:
Levels of some urinary eicosanoids and serum interleukins during fish oil treatment in IgAN

Agrawal, S.M.; Omeljaniuk, R.J., 2000:
Levels of specifically bound ketanserin compared with levels of serotonin in the brain regions of juvenile and sexually recrudescing female rainbow trout, Oncorhynchus mykiss

Slavov, M., 2003:
Levels of sperm - antibodies in andrological patients with urogenital infections and testicular disorders using the direct sperm - MAR test and the direct Immunobead test

Philp, L.; Holloman, E.; Field, M.J.; Williams, R.G., 1999:
Levels of spinal alpha2delta protein and mRNA in a rat model of neuropathic pain

Fromme, H.; Otto, T.; Pilz, K.; Neugebauer, F., 1999:
Levels of synthetic musks; bromocyclene and PCBs in eel and PCBs in sediment samples from some waters of Berlin / Germany

Veng, L.M.; Nixon, K.M.; Mesches, M.H.; Browning, M.D., 2001:
Levels of the L-type calcium channel subunit alpha1D are reduced in aged rat hippocampus

Sturk, L.; Hall, J.E.; Holman, J.A.; Kalvass, C.; Tidwell, R.R., 2003:
Levels of the anti-trypanosomal prodrug 2,5-bis furan-O-bis-amidoxime and its metabolites within murine brain tissue

Bulgakova, V.A.; Sentsova, T.B., 2001:
Levels of the interleukin-2 and interleukin-6 in children with atopic dermatitis

Batpenova, Gulnara, 2003:
Levels of the ionized calcium and 25-oxyergolcalcepherol in children with exudative psoriasis

Washabaugh, C.H.; Ontell, M.P.; Tajbakhsh, S.; Kant, J.A.; Ontell, M., 2002:
Levels of the three remaining myogenic regulatory factors in muscles of myf-5 null mice

Madhok, A.B.; Chandrasekran, A.; Parnell, V.A.; Chowdhury, D.; Pahwa, S., 2003:
Levels of thymic recent emigrant cells decreases in children undergoing thymectomy during cardiac surgery

Zaitseva, T.; Schears, G.; Schultz, S.; Creed, J.; Wilson, D.F.; Pastuszko, A., 2003:
Levels of total and phosphorylated cyclic AMP response binding protein in striatum following cardiopulmonary bypass

Marquez, M.; Vodopivez, C.; Casaux, R.; Curtosi, A., 1999:
Levels of total mercury in Antarctic organisms from King George Island, South Shetland Islands, Antarctica

Charjan, P.; Mangle, N.S.; Kalorey, D.R.; Kuralkar, S.V., 2003:
Levels of total whey protein and immunoglobulin in udder health status of cow

Gouteux, B.; Lebeuf, M.; Gagne, J.P., 2000:
Levels of toxaphene congeners in a marine food web from the St Lawrence Estuary, Canada

Dobrikova, E.Y.; Cabello, F.C., 2000:
Levels of transcription and promoter identification of Borrelia burgdorferi bmp genes

Tsianos, E.V.; Christodoulou, D.K.; Katsanos, K.H.; Eleftheriou, A.; Gartzonika, K.; Mavridis, A., 2000:
Levels of transferrin, haptoglobulins and factor B of properdine in patients with inflammatory bowel disease

Dimitrakopoulos, C.; Gouzoumas, N.; Karvounis, H.; Styliadis, I.; Nouskas, I.; Karamouzis, M.; Parharidis, G.; Louridas, G., 2001:
Levels of troponin I, ANP and c-GMP as indices of improvement of left ventricular function after DDD pacing for complete AV-block

Odeh, M.; Sabo, E.; Srugo, I.; Oliven, A., 2002:
Levels of tumor necrosis factor-alpha correlate with polymorphonuclear leukocyte count in complicated parapneumonic effusion

Bradley, L.A.; Palomaki, G.E.; Knight, G.J.; Haddow, J.E.; Opitz, J.M.; Irons, M.; Kelley, R.I.; Tint, G.S.ephen, 1999:
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz syndrome fetuses

Milanese, G.; Muzzonigro, G.; Galosi, A.B.; Vivani, C.; Sier, C.F.M.; Blasi, F.; Fazioli, F., 2000:
Levels of urokinase-type plasminogen activator receptor in serum and urine of bladder cancer patients Preliminary results

Blann, A.D.; Belgore, F.M.; Lip, P.L.; Lip, G.Y.H., 2000:
Levels of vascular endothelial growth factor and its receptor Flt-1 in type 2 diabetes with or without atherosclerosis

Lee, S.S.ok; Joo, Y.S.il; Kim, W.U.; Min, J.K.; Hong, Y.S.k; Lee, S.H.on; Park, S.H.an; Cho, C.S.o; Kim, H.Y.un, 1999:
Levels of vascular endothelial growth factor in serum and synovial fluid of patients with rheumatoid arthritis

Onuoha, G.N.; Alpar, E.K., 2001:
Levels of vasodilators and vasoconstrictor peptides in early human burns

Sester, M.; Sester, U.; Gaertner, B.; Heine, G.; Girndt, M.; Mueller Lantzsch, N.; Meyerhans, A.; Koehler, H., 2000:
Levels of virus-specific CD4 T-cells correlate with cyto-megalovirus control and predict virus-induced disease following renal transplantation

Parker, J.; Hashmi, O.; Dutton, D.; Mavrodaris, A.; Stranges, S.; Kandala, N-Bakwin.; Clarke, A.; Franco, O.H., 2010:
Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis

Martin, A.; Bermudez, O.I.; Youdim, K.; Joseph, J.A.; Tucker, K.L., 2000:
Levels of vitamin E, ICAM-1 and arachidonic acid in an elderly Hispanic and non-Hispanic population Implications to the well-being of elders

Cardigan, R.; Allford, S.; Williamson, L., 2002:
Levels of von Willebrand factor-cleaving protease are normal in methylene blue-treated fresh-frozen plasma

Hirsch, R.; Ostchega, Y.; Guralnik, J., 1999:
Levels of walking speed and lower extremity joint involvement in older US adults

Ciric, D.; Ciric, M.; Jovic, M.; Djordjevic, R.; Boskovic, D.; Stankovic, S., 1999:
Levels prolactin and TSH to haloperidol in schizophrenic patients before and after treatment

Caggiano,R.; Macchiato,M.; Trippetta,S., 2010:
Levels, chemical composition and sources of fine aerosol particles in an area of the Mediterranean basin

Imai, K.; Mori, Y., 1999:
Levels, inheritance and stability of resistance to Bacillus thuringiensis formulation in a field population of the diamondback moth, Plutella xylostella from Thailand

Forkey, J.N.; Keleti, D.; Shaw, M.A.exander; Goldman, Y.E., 2004:
Lever arm angles in single-headed proteolytic fragments of myosin V

Reno, Waldix Teixeira, 2001:
Lever retractor for surgical flaps with handle

Baron, R.J.; Arndt, R.; Blinow, I., 2001:
Lever-style drain assembly for urine collection container

Mullaney, B.P.; Williams, K.; Pytela, R.; Pallavicini, M., 2002:
Leveraging immune diversity and mass spectrometry by antibody proteomics

Pegg, S.C.H.; Babbitt, P., 2003:
Leveraging information from enzyme superfamily studies

Nash, Elby, 2003:
Leveraging knowledge assets to accelerate discovery An introduction

Skingle, Malcolm, 2001:
Leveraging technology through academic-industrial collaboration

Ardid, D.; Lamberty, Y.; Alloui, A.; Coudore Civiale, M.A.; Eschalier, A., 2001:
Levetiracetam , a new antiepileptic drug, is effective in neuropathic but not acute pain models in rats

Klitgaard, H.; Matagne, A.; Grimee, R.; Goemaere, J.; Margineanu, D., 1999:
Levetiracetam /UCB L059 protects against pilocarpine-induced seizures in rats Characterization of electrophysiological and biochemical effects and identification of brain areas involved

Lippmann, S.M.; Montouris, G.D.; Rosenfeld, W.E.; Schaefer, P.A., 2002:
Levetiracetam A helpful new drug

Dooley, M.; Plosker, G.L., 2000:
Levetiracetam. A review of its adjunctive use in the management of partial onset seizures

Isik, U.; Greenwod, R.S.; Tennison, M.B.; Boyce, L.H.; D'cruz, O'neill F., 2001:
Levetiracetam A single center experience

Nohria, V.; Leppik, I.E.; Verdru, P.; Debrabandere, L., 1999:
Levetiracetam Evaluation of success rate in secondarily generalized seizures in addition to activity in partial seizures

Van Rijckevorsel, Kenou, 2000:
Levetiracetam Evaluation of the number needed to treat

Niespodziany, I.; Klitgaard, H.; Margineanu, D.G.org, 2000:
Levetiracetam Modulation of high voltage-activated Ca2+ current in Ca1 pyramidal neurons of rat hippocampal slices

Hans, G.; Nguyen, L.; Rocher, V.; Belachew, S.; Moonen, G.; Matagne, A.; Klitgaard, H., 2000:
Levetiracetam No relevant effect on ionotropic excitatory glutamate receptors

Rigo, J.M.; Nguyen, L.; Belachew, S.; Mulgrange, B.; Leprince, P.; Moonen, G.; Selak, I.; Matagne, A.; Klitgaard, H., 2000:
Levetiracetam Novel modulation of ionotropic inhibitory receptors

Koukkari, M.W.; Guarino, T.J., 2002:
Levetiracetam Retrospective experience in pediatric patients with multiple seizure types

Leppik, I.E.; Gauer, L., 2000:
Levetiracetam Serious adverse experiences and SUDEP

Kramer, G.; Hosli, I.; Glanzmann, R.; Holzgreve, W., 2002:
Levetiracetam accumulation in human breast milk

Bastlund, J.F.; Watson, W.P.; Sanchez, C., 2002:
Levetiracetam and phenytoin show greater efficacy at reducing nicotine-kindled seizures than PTZ-kindled seizures in mice

Mushtaq, R.; Wannamaker, B.B., 2002:
Levetiracetam blood levels have utility in clinical management of epilepsy

Imperiale, D.; Bortolotto, S.; Cucatto, A.; Schiffer, P.; Cassano, D.; Buffa, C., 2003:
Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease

Perucca, E.; Gidal, B.E.; Ledent, E.; Baltes, E., 2000:
Levetiracetam does not interact with other antiepileptic drugs

Scuvee Moreau, J.; Thomas, E.; Seutin, V., 2002:
Levetiracetam does not modulate SK channel activity in CA1 hippocampus pyramidal cells in vitro

Baltez, E.; Coupez, R., 2000:
Levetiracetam dose adjustment for patients on hemodialysis

Hovinga, C.; Morris, H.; Holland, K.; Foldvary, N.; Kotagal, P.; Wyllie, E., 2001:
Levetiracetam efficacy in adults and children

Klitgaard, H.; Matagne, A., 2002:
Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in amygdala-kindled rats

Matagne, A.C.; Baltes, E.; Coupez, R.; Patsalos, P.N.; Klitgaard, H.V. , 2001:
Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in audiogenic susceptible mice

Crawford, P.; Danniau, A.; Waegemans, T., 1999:
Levetiracetam for the treatment of refractory epilepsy Tolerability and efficacy as add-on treatment without up-titration period

Niespodziany, I.; Klitgaard, H.; Margineanu, D.G., 2000:
Levetiracetam had no effect on the low-voltage-activated Ca2+ current in rat CA1 hippocampal neurons

Litzinger, M.J.; Hanny, A., 2002:
Levetiracetam has a positive response in refractory pediatric partial seizure patients with visual triggers

Dedeurwaerdere, S.M.; Claeys, P.; Raedt, R.A.; D.S.edt, T.; Vonck, K.; Grisar, T.; Boon, P.A.J.M., 2003:
Levetiracetam has antiepileptogenic properties in GAERS

Dedeurwaedere, S.; Claeys, P.; D.S.edt, T.; Raedt, R.; Vonck, K.; Grisar, T.; Boon, P., 2004:
Levetiracetam has antiepileptogenic properties in genetic absence epilepsy rats from Strasbourg

Mandler, R.N.; Choi, J.M.; Kingery, E.R.; Barber, A.M., 2003:
Levetiracetam improves cerebellar tremor in multiple sclerosis

Rüegg, S.J.; Steck, A.J.; Fuhr, P., 2004:
Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome

Papavasiliou, A.; Korkoli, E.; Paraskevoulakos, E.; Kotsalis, C., 2004:
Levetiracetam in childhood treatment-resistant epilepsy

Mordekar, S.R.; Peake, D.; Philip, S.; Gosalakkal, J.; Rittey, C.D.R.; Whitehouse, W.P., 2004:
Levetiracetam in children with intractable epilepsy preliminary results of a clinical audit

Kraemer, G.; Edrich, P., 2001:
Levetiracetam in elderly patients with epilepsy

Wasterlain, C.G.; Mazarati, A.M.; Klitgaard, H.V.; Baldwin, R.A., 2001:
Levetiracetam in experimental status epilepticus

Vigevano, F., 2004:
Levetiracetam in paediatrics

Cramer, J., 2000:
Levetiracetam in partial epilepsy Results of pooled data

Ferrendelli, J.; French, J.; Leppik, I.; Morrell, M.J.; Magnus, L., 2003:
Levetiracetam in patients aged gtoreq65 years A subset of the KeeperTM Trial

Johannessen, S.I.; Helde, G.; Brodtkorb, E., 2004:
Levetiracetam in pregnancy and lactation preliminary observations

Krakow, K.; Otoul, C.; Walker, M.C.; Sander, J.W., 2000:
Levetiracetam in refractory epilepsy Predictors of long-term retention

Kkolou, E.; Papacostas, S., 2004:
Levetiracetam is effective and well-tolerated in patients with intractable epilepsy

L.N.ve, A.; Boero, G.; Specchio, N.; Santosabato, M.; D.P.lo, A.; D.A.azio, G.; Specchio, L.M., 2004:
Levetiracetam is effective in juvenile myoclonic epilepsy

Lindholm, Dwight, 2002:
Levetiracetam levels correlating with successful treatment of epilepsy, headaches, cognitive effects, and adverse reactions in pediatric age group

Alsaadi, T.M.; Thieman, C., 2002:
Levetiracetam monotherapy for adults with epilepsy

Arrigo, A.; Raiteri, U.; Ardizzone, G.; Regesta, G.; Ottonello, G.A., 2004:
Levetiracetam monotherapy for the treatment of partial status epilepsy in a patient following a liver transplant

Mintz, M.; Graner, C.A.n; Blumenfeld, S.; Alberts, L., 2002:
Levetiracetam monotherapy in pediatric patients

Resor, S.R.; Resor, L.R., 2002:
Levetiracetam monotherapy in the treatment of convulsive seizures in patients with juvenile myoclonic epilepsy

French, J.A.; Cramer, J.; Edrich, P., 2001:
Levetiracetam overall safety profile

Ghattaura, S.; Ratnaraj, N.; Sander, J.W.; Patsalos, P.N., 2004:
Levetiracetam pharmacokinetics in patients with intractable epilepsy

Barrueto, F.; Williams, K.; Howland, M.A.; Hoffman, R.S.; Nelson, L.S., 2002:
Levetiracetam poisoning induces coma Confirmed by laboratory analysis

Hill, M.P.; Ravenscroft, P.; Bezard, E.; Crossman, A.R.; Brotchie, J.M.; Michel, A.; Grimee, R.; Klitgaard, H., 2003:
Levetiracetam potentiates the anti - dyskinetic action of amantadine in the MPTP - lesioned marmoset model of Parkinsons disease

Bezard, E.; Brotchie, J.M.; Crossman, A.R.; Hill, M.P.; Michel, A.; Grimee, R.; Klitgaard, H.V., 2003:
Levetiracetam reduces L-DOPA-induced choreic dyskinesia in the MPTP-lesioned macaque

Brotchie, J.M.; Bezard, E.; Crossman, A.R.; Hill, M.P.; Michel, A.; Grimee, R.; Klitgaard, H.V., 2003:
Levetiracetam reduces L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset model of parkinsons disease

Angehagen, M.; Margineanu, D.G.org; Ronnback, L.; Hansson, E.; Klitgaard, H.; Ben Menachem, E., 2002:
Levetiracetam reduces caffeine-induced intracellular calcium transients in cultured rat hippocampal neurons

Gallagher, M.J.; Attarian, H.; Fessler, A.J.mes; Eisenman, L.N.; Altay, E.E.bayat; Dong, J.; Hecimovic, H.; Gilliam, F., 2002:
Levetiracetam reduces interictal spike-wave complexes in patients with idiopathic generalized epilepsy

Coupez, R.; Straetemans, R.; Sehgal, G.; Armel, S.; Lu, Z., 2004:
Levetiracetam relative bioavailability and bioequivalence of 10% oral solution and 750 Mg tablets

Lukyanetz, E.A.; Shkryl, V.M.; Kostyuk, P.G., 2001:
Levetiracetam selectively blocks N-type calcium channels in rat isolated CA1 hippocampal neurons

Werz, M.A.n; Lang, P.; Rienzo, T., 2003:
Levetiracetam therapy for epilepsy Use and tolerability in the elderly

Franz, D.N.; Leonard, J.M.; Tudor, C.A.; Chuck, G.; Egelhoff, J., 2002:
Levetiracetam therapy of epilepsy in tuberous sclerosis

Locatelli, P.; Lapadula, G.; Casari, S.; E.H.med, I.; Uccelli, C.; Vignolo, L.A., 2004:
Levetiracetam use in patients with HIV infection and retroviral therapy

Martien, Katherine M., 2003:
Levetiracetam utility in autistic children limited by behavioral side effects

Molsa, P.K., 2004:
Levetiracetam versus gabapentin as adjunctive therapy in the treatment of catastrophic epilepsy

Gidal, B.E.; Sheth, R.; Maganti, R.; Magnus, L.; Herbeuval, A.F.ancoise, 2001:
Levetiracetam weight change during placebo-controlled clinical trials

Kimland, E.; Höjeberg, B.; von Euler, M., 2004:
Levetiracetam-induced thrombocytopenia

Mesad, S.M.; Devinsky, O., 2002:
Levetiracetam-related aggression

Goldstein, J.L.; Trevathan, E.; Arnold, S.T.; Dodson, W.E.win, 2001:
Levetiracitam Exacerbation of epilepsy

Korby, B.; Penovich, P.E.; Gates, J.R.; Dickens, D.L.; Moriaraty, G.L., 2003:
Leviteracetam monotherapy

Rasmini, P.; Besana, D.; Giribone, S., 2004:
Levitracetam as add-on therapy in childhood drug resistant epilepsy

Tillman, T.N.; Thompson, D.L.; Rafool, G.J., 2000:
Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent

Foster, R.H.; Markham, A., 2000:
Levobupivacaine: a review of its pharmacology and use as a local anaesthetic

Munir, M.A.; Li, H.; Jaffar, M.; Ghaleb, A.; Zhang, J.M.ng, 2003:
Levobupivacaine Blocks Lumbar Ganglion Compression-Induced Mechanical Hyperalgesia and Allodynia beyond Its Duration of Action

Urbanek, B.; Duma, A.; Kimberger, O.; Marhofer, P.; Kapral, S., 2002:
Levobupivacaine Versus Bupivacaine for 3-in-1 Blocks

Glaser, C.; Marhofer, P.; Zimpfer, G.; Kapral, S.; Schindler, I., 2002:
Levobupivacaine Versus Bupivacaine for Spinal Anesthesia

Ivani, G.; D.N.gri, P.; Grossetti, R.; Vercellino, C.; Gagliardi, F., 2002:
Levobupivacaine Vs Ropivacaine Vs Bupivacaine in Pediatric Caudal Anesthesia

Mather, L.E.; Richards, A.J.hn Mcglashan, 2003:
Levobupivacaine and its use

Bardsley, H.J.dith; Gristwood, R.W.lliam; Richards, A.J.hn Mcglashan, 2002:
Levobupivacaine as an analgesic agent

Gunter, J.B.; Gregg, T.; Varughese, A.M.; Wittkugel, E.P.; Berlin, R.E.; Ness, D.A.; Overbeck, D.E., 1999:
Levobupivacaine for ilioinguinal/iliohypogastric nerve block in children

Bardsley, H.J.dith; Mather, L., 1999:
Levobupivacaine for managing chronic pain

Herroeder, S.; Kurz, K.S.; Durieux, M.E.; Berkelmans, N.S.; Hollmann, M.W., 2002:
Levobupivacaine inhibits neutrophil priming more profoundly than does bupivacaine

Pistone, G.; Marino, A.; Leotta, C.; Dell'Arte, S.; Finocchiaro, G.; Malaguarnera, M., 2003:
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue

Clutterbuck, E.J.; Laffan, M., 2002:
Levocarnitine supplementation improves red blood cell survival and clinical symptoms in haemodialysis patients

Pellet, C.; Jean Louis, F.; Boland, S.; Dubertret, L.; Michel, L., 2004:
Levocetirizine decreases VCAM-1 expression induced by TNF-alpha in human dermal endothelial cells through down-regulation of NF-kappaB pathway

Thomson, L.; Blaylock, M.G.; Walsh, G.M., 2001:
Levocetirizine inhibits eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells

Nakamori, S.; Shimizu, S.; Wada, M., 2002:
Levodione reductase

Harder, S.; Dietz, M.; Leenders, K.; Baas, H., 1999:
Levodopa PK-PD-analysis in relation to F-Dopa-PET in patients with Parkinsons disease

Agid, Y.; Olanow, C.W.; Mizuno, Y., 2002:
Levodopa: why the controversy?

Black, K.J.; Hershey, T.; Akbudak, E.; Snyder, A.Z.; Barch, D.; Carl, J.L.; Conturo, T.E.; Hartlein, J.M.; Koller, J.M.; Perlmutter, J.S., 2003:
Levodopa activation pharmacologic fMRI in Tourettes syndrome

Steiner, I.; Wirguin, I., 2003:
Levodopa addiction in non-parkinsonian patients

Grondin, R.; Zhang, Z.; Gerhardt, G.A.; Gash, D.M., 1999:
Levodopa and GBR-12909 improve fine motor performance in aged rhesus monkeys

Luquin, R.; Del Rio, L.; Saldise, L.; Setuain, J.; Manzi, B., 2001:
Levodopa but not pergolide administration induces apoptosis in the substantia nigra neurons of rats with partial nigrostriatal lesion

Müller, U.; Reuter, M.; Hermann, W.; Gertz, H.J., 2002 :
Levodopa dependency in Parkinson's disease: case report and review

Payoux, P.; Brefel Courbon, C.; Quelven, I.; Thalamas, C.; Galitzky, M.; Chollet, F.; Esquerre, J.P.; Rascol, O., 2003:
Levodopa effect on experimental pain in Parkinson disease A PET activation Study

Rumbach, L.; Bouhaddi, M.; Vuillier, F.; Sablot, D.; Capelle, S.; Chavot, D.; Henriet, M.T.erese; Moulin, T.; Regnard, J., 2001:
Levodopa impairs baroreflex adjustment of circulatory homeostasis in Parkinsons Disease

Kelly, V.E.; Hyngstrom, A.J.; Bastian, A.J., 1999:
Levodopa improves non-cued reaching more than cued reaching in Parkinsons disease

Murer, M.G.; Raisman-Vozari, R.; Gershanik, O., 1999:
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Muller, T.; Woitalla, D.; Fowler, B.; Przuntek, H.; Kuhn, W., 2001:
Levodopa induced altered O-methylation in parkinsonian subjects

Feigin, A.; Mentis, M.J.; Dhawan, V.; Margouleff, C.; Eidelberg, D., 2000:
Levodopa infusion reduces the expression of a Parkinsons disease metabolic brain network An FDG PET study

Gonzalez Hernandez, B.; Silva, I.; Rangel, C.; Floran, L.; Aceves, J.; Floran, B., 2002:
Levodopa via d2 receptors inhibits gaba release in the rat globus pallidus of 6 hydroxydopamine lesioned rats

Metman, L.Verhagen, 2001:
Levodopa-associated dyskinesias Clinical features and treatment strategies

Loeffler, D.A.; Camp, D.M.; Mendiratta, M.; Yagiela, H.; Lewitt, P.A.; Hyland, K., 1999:
Levodopa-induced alterations in regional brain concentrations of norepinephrine, serotonin and their metabolites in 6-OHDA hemilesioned rats

Martel, J.C.; Colpaert, F.C.; Marien, M., 1999:
Levodopa-induced changes in striatal extracellular levels of dopamine and metabolites in nigrostriatal-lesioned rats in vivo Effects of -idazoxan

Togasaki, D.M.; Tan, L.; Protell, P.; Delanney, L.E.; D.M.nte, D.A.; Quik, M.; Langston, J.W., 2000:
Levodopa-induced dyskinesias in unlesioned monkeys

Yasui, K.; Nakaso, K.; Kowa, H.; Takeshima, T.; Nakashima, K., 2003:
Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

Marin, C.; Bove, J.; Jimenez, A.; Bonastre, M.; Molinuevo, J.L.; Tolosa, E., 2000:
Levodopa-induced motor fluctuations are dissociated from striatal c-jun expression in parkinsonian rats

van Laar, T., 2003:
Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management

Fobelo Lozano, M.J.; Miguel Del Corral, M., 1999:
Levodopa/Carbidopa solution in advanced Parkinsons disease patients

Kaseda, S.; Tsujimura, S.; Mitsuda, M.; Osame, M.; Nomoto, M., 2001:
Levodopa/benserazide tablets showed higher bioavailability of levodopa than levodopa/carbidopa tablets

Mahgoub, S.; Hochstein, L.; Kopetz, V.; LaBombardi, V.; Leggiadro, R.; Glatt, A.E., 2003:
Levoflaxin and Streptococcus pneumoniae

Harding, I.; Simpson, I., 2001:
Levofloxacin A cost-effective agent for the treatment of community acquired pneumonia

Croom, K.F.; Goa, K.L., 2003:
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States

Harding, I.; Simpson, I.; O'hare, M., 2001:
Levofloxacin A safe and well tolerated fluoroquinolone

Hurst, M.; Lamb, H.M.; Scott, L.J.; Figgitt, D.P., 2002:
Levofloxacin: an updated review of its use in the treatment of bacterial infections

Simpson, I.; Harding, I., 2001:
Levofloxacin Factors responsible for the low potential for resistance development among isolates of Streptococcus pneumoniae

Simpson, I.N.; Harding, I., 2001:
Levofloxacin Low potential for fluoroquinolone-resistance development among Streptococcus pneumoniae

O'hare, M.; Simpson, I., 2001:
Levofloxacin Review of efficacy and tolerability, relative to beta-lactams+-macrolides, in the treatment of community-acquired pneumonia

Simpson, I.N.; Harding, I., 2001:
Levofloxacin Review of tolerability and safety

Harding, I.; Simpson, I., 2001:
Levofloxacin The criterion AUC/MIC30 provides a robust model for predicting clinical outcome against Streptococcus pneumoniae

Hoban, D.J.; Karlowsky, J.A.; Zhanel, G.G., 1999:
Levofloxacin activity against recent Canadian respiratory tract pathogens

Phung, P.; Tong, T.; Gurevitch, M.; Wong Beringer, A., 2000:
Levofloxacin and cefotaxime, alone versus in combination for the treatment of community-acquired pneumonia in hospitalized patients Impact on medical outcomes

Schaeffer, A.J.; Wu, S.C.en; Tennenberg, A.M.; Zadeikis, N., 2004:
Levofloxacin and ciprofloxacin in the treatment of chronic bacterial prostatitis lower serum prostate specific antigen

Clark, C.L.; Jacobs, M.R.; Appelbaum, P.C., 1999:
Levofloxacin and clarithromycin antipneumococcal activity

Rudnic, E.M.; Isbister, J.D.; Treacy, D.J.J.; Wassink, S.E., 2003:
Levofloxacin antibiotic product, use and formulation thereof

Mitrokhin, S.D., 2003:
Levofloxacin antimicrobial activity

Timmers, G.J.; Simoons Smit, I.M.; Van Winkelhoff, A.J.; Dijstelbloem, Y.; Touw, D.; Vandenbroucke Grauls, C.M.; Huijgens, P.C., 2000:
Levofloxacin as antibacterial prophylaxis in neutropenic patients with hematological malignancies

Chiang, F.Y.; Mudduluru, M.; Alcid, D., 2000:
Levofloxacin associated increase in methicillin-resistant staphylococcus aureus infections

Yakovlev, S.V.; Yakovlev, V.P., 2002:
Levofloxacin at the treatment of respiratory tract infections

Festa, V.; Perri, F.; Boschetto, S.; Giovannone, M.; Tosoni, M.; Andriulli, A.; Barberani, F., 2002:
Levofloxacin based triple therapy as second-line treatment for H pylori infection after failure of standard triple therapy

Oksanen, A.M.; Rautelin, H., 2003:
Levofloxacin combination therapy for clarithromycin and metronidazole resistant Helicobacter pylori strains

Friedlaende, M.H.; Rubin, J.M.; Padilla, E.; Amdahl, L.D., 2000:
Levofloxacin concentration in tears following topical administration of 05% levofloxacin ophthalmic solution in healthy volunteers

Iannini, P.B., 2001:
Levofloxacin delays cardiac repolarization in hospitalized patients

Bellmann, R.; Egger, P.; Pechlaner, C.; Feistritzer, C.; Vogel, W.; Joannidis, M.; Wiedermann, C.J., 2003:
Levofloxacin elimination during albumin dialysis

O'hare, M.; Simpson, I., 2001:
Levofloxacin for the treatment of acute bacterial sinusitis

Harding, I.; O'hare, M., 2001:
Levofloxacin for the treatment of community acquired pneumonia Clinical advantages over other empiric therapies

O'hare, M.; Harding, I., 2001:
Levofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis Advantages over currently available therapies

Felmingham, D.; Harding, I., 2001:
Levofloxacin for treatment of respiratory tract infections Excellent in vitro activity and low prevalence of resistance

O'hare, M.; Harding, I., 2001:
Levofloxacin has low potential for cardiovascular adverse reactions

Kahn, J.B.; Wiesinger, B.A.; Khanna, M., 1999:
Levofloxacin in the management of community-acquired pneumonia due to penicillin- and multiple drug-resistant pneumococci

Kahn, J.B.; Wiesinger, B.A.; Morgan, N., 2000:
Levofloxacin in the treatment of bacteremic pneumococcal pneumonia

Kahn, J.B.; Wiesinger, B.A.; Scott Marshall, J.A.n; Olson, W.H., 2000:
Levofloxacin in the treatment of community-acquired pneumonia due to penicillin-resistant and -susceptible pneumococci and other pathogens

Perry, A.; Rouse, M.S.; Piper, K.E.; Hanssen, A.D.; Steckelberg, J.M.; Patel, R., 2001:
Levofloxacin inhibits fracture healing in a rat model of implant stabilized experimental fractures

Simpson, I.; Jones, N., 2001:
Levofloxacin is at least as safe and effective as ciprofloxacin and lomefloxacin in the treatment of intra-abdominal, urinary tract and skin and soft tissue infections

Kawada, A.; Aragane, Y.; Tezuka, T., 2002:
Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study

Simpson, I.N.; Harding, I., 2001:
Levofloxacin is not associated with significant hepato-biliary adverse reactions

Yu, Y.L.; Williams, R.R.; Stout, J.E.; Greenberg, R.N.; Kojak, C.M., 2001:
Levofloxacin is safe and effective in the management of community-acquired pneumonia due to Legionella

Shvab, M.; Lobel, S.; Scheuering, S.; Kisch, A.L., 2000:
Levofloxacin misuse in the emergency department An expensive hospital liability

Ibrahim, K.H.; Hovde, L.B.; Brown, G.H.; Rotschafer, J.C., 1999:
Levofloxacin pharmacodynamics vs Streptococcus pneumoniae

Chung, E.; Drusano, G.L.; Nafziger, A.N.; Bertino, J.S.J., 2003:
Levofloxacin pharmacokinetics in patients with community acquired pneumonia and varying severity of illness as assessed by the pneumonia severity index

Lucksiri, A.; Kays, M.B.; Hamburger, R.J.; Mueller, B.A.; Scott, M.K.; Sowinski, K.M., 2001:
Levofloxacin pharmacokinetics in patients with end-stage renal disease

Harr, M.S.; Hutcheson, J.A.; Laurent, A.L.; Graves, A.L.; Van Buskirk, A.L., 2000:
Levofloxacin plasma concentrations following topical administration of 05% levofloxacin ophthalmic solution in healthy adult volunteers

Nomura, H.; Tsutsumi, N.; Terasaka, R., 1999:
Levofloxacin prevented liver abscess and suppurative cholecystitis following transcatheter arterial embolization for hepatocellular carcinoma

Nazir, J.; Urban, C.; Mariano, N.; Burns, J.; Segal Maurer, S.; Rahal, J.J., 2002:
Levofloxacin resistant Haemophilus influenzae in a long term care facility

Anderson, D.M.; Dudas, V., 2003:
Levofloxacin resistant Streptococcus pneumoniae An evaluation of isolates and patients from 2000-2002

Wehbeh, W.; Rojas Diaz, R.; Mariano, N.; Grenner, L.; Segal Maurer, S.; Urban, C.; Rahal, J.J., 2003:
Levofloxacin resistant group B streptococci

O'hare, M.; Harding, I., 2001:
Levofloxacin therapy for community-acquired pneumonia due to atypical and intracellular microorganisms

Davidson, R.J.; D.A.avedo, J.; Bast, D.; Arbique, J.; Bethune, R.; Duncan, C.; Mcgeer, A.; Low, D.E., 2000:
Levofloxacin treatment failure of pneumococcal pneumonia and development of resistance during therapy

Nickel, J.C.rtis; Downey, J.; Clark, J.; The Canadian Prostatitis Research Group, 2003:
Levofloxacin treatment for chronic prostatitis/chronic pelvic pain syndrome in men A randomized placebo controlled multi-center trial

Tsai, C-Chi.; Lay, C-Jang.; Wang, C-Lung.; Ho, Y-Huai.; Wang, L-Shinn.; Chen, L-Kuang., 2010:
Levofloxacin versus tetracycline antibiotics for the treatment of scrub typhus

Kahn, J.B.; Wiesinger, B.A.; Oross, M.P.; Olson, W.H., 2000:
Levofloxacin vs ceftriaxone and erythromycin followed by clarithromycin and amoxicillin/clavulanate in serious community-acquired pneumonia

Kahn, J.B.; Wiesinger, A.; Olson, W.H.; Oross, M.; Reichl, V., 2001:
Levofloxacin vs ceftriaxone sodium and erythromycin in the treatment of patients with community-acquired pneumonia at high risk of mortality

Simpson, I.; Harding, I., 2001:
Levofloxacin, ofloxacin and ciprofloxacin are poor inhibitors of the HERG channel and have little ability to prolong QT interval

Solomon, N.M.; Mokrzycki, M.H., 2000:
Levofloxacin-induced allergic interstitial nephritis

Klugman, K.P., 2000:
Levofloxacin-resistant pneumococcus

Micheletto, C.; Tognella, S.; Pomari, C.; Dal Negro, R., 2002:
Levofloxacine in the exacerbations of COPD due to Pseudomonasae

Mccabe, H.L.; Lind, M.J.; Wilkinson, S.; Maraveyas, A., 2001:
Levomepromazine has efficacy in delayed chemotherapy induced emesis following platinum-based treatment

Aukst-Margetić, B.; Margetić, B.; Tosić, G.; Bilić-Prcić, A., 2004:
Levomepromazine helps to reduce sleep problems in patients with PTSD

Sgouros, J.; Neville Webb, H.; Bunton, S.; Lind, M.J.; Maraveyas, A., 2003:
Levomepromazine versus Dexamethasone with Metoclopramide in the prevention of cisplatin induced delayed emesis Preliminary results of a randomized Study

Kenneth Koe, B., 1999:
Levonantradol

Sevestre, H.P., 2003:
Levonorgestrel releasing intrauterine device Clinicopathological correlation

Swan, C.L.; Crellin, N.K.; Chedrese, P.J., 2000:
Levonorgestrel stimulated progesterone synthesis is not altered by progesterone receptor antagonists in a stable porcine granulosa cell line

Skrumsager, B.K.; Muller, M.; Kiehr, B., 1999:
Levormeloxifene Safety and pharmacokinetics in young versus elderly postmenopausal women

Hey, A.; Norgaard, K., 2000:
Levormeloxifene a non-steroid partial estrogen receptor agonist inhibits growth of MCF-7 breast tumors by arresting cells in G1-phase of the cell cycle

Hotchkiss, C.E.; Stavisky, R.; Nowak, J.; Kaplan, J., 1999:
Levormeloxifene prevents increased bone turnover and trabecular bone loss following ovariectomy in cynomolgus monkeys

Cleland, J.G.F.; McGowan, J., 2002:
Levosimendan: a new era for inodilator therapy for heart failure?

Innes, C.A.; Wagstaff, A.J., 2003:
Levosimendan: a review of its use in the management of acute decompensated heart failure

Toller, W.G.; Pagel, P.S.; Kersten, J.R.; Warltier, D.C., 2000:
Levosimendan Treatment of heart failure, calcium sensitizer, KATP channel activator -OR-1259 SimdaxTM

Toller, W.G.; Montgomery, M.W.; Kersten, J.R.; Pagel, P.S.; Warltier, D.C., 1999:
Levosimendan decreases myocardial infarct size via activation of adenosine triphosphate Dependent potassium channels

Delle Karth, G.; Heinz, G., 2004:
Levosimendan in cardiology and intensive care medicine

Franco, F.; Goncalves, F.; Castro, G.; Morais, M.E.ilia; Andrade, C.; Goncalves, L.; Freitas, M.; Providencia, L., 2003:
Levosimendan is beneficial in diabetics with acute heart failure

Franco, F.; Goncalves, F.; Castro, G.; Morais, M.E.ilia; Andrade, C.; Goncalves, L.; Freitas, M.; Providencia, L.A., 2003:
Levosimendan is efficacious in acute heart failure independent of renal function

Franco, F.; Monteiro, P.; Correia, J.; Roque, C.; Goncalves, F.; Castro, G.; Goncalves, L.; Freitas, M.; Providencia, L.A., 2004:
Levosimendan is safe and effective in patients with severe low cardiac output heart failure and critical hypotension

Maytin, M.; Ito, M.; Sawyer, D.B.; Slawsky, M.T., 2003:
Levosimendan protects cardiac myocytes from oxidant stress-induced apoptosis via activation of mitochondrial ATP-dependent K-channels

Rajek, A.M.; Koinig, H.; Jelen, M.; Schiferer, A.; Hutschala, D., 2003:
Levosimendan, a New Ca-Sensitizer, in Patients with Poor Left Ventricular Function Undergoing Cardiac Surgery

Distrutti, E.; Fiorucci, S.; Pensi, M.O.; Vanasia, M.; Cammilleri, F.; Morelli, A., 1999:
Levosulpiride decreases perception of rectal distention in healthy subjects and IBS patients

Mearin, F.; Rodrigo, L.; Perez Mota, A.; Balboa, A.; Jimenez, I.; Sebastian, J.J.se; Paton, C., 2003:
Levosulpiride in the treatment of dysmotility like functional dyspepsia randomised double dimmed comparison with cisapride

Troshina, K.A.; Veldanova, M.V.; Mazurina, N.V.; Dedov, I.I., 2000:
Levothyroxine and potassium iodide are effective in treatment of benign solitary nodules of the thyroid

Franz, G.A.drew; Strauss, E.A.; Dimenna, P.A.; Gemma, R.L., 2003:
Levothyroxine compositions and methods

Yaylali, O.; Yuksel, D.; Kirac, F.S., 2000:
Levothyroxine treatment and bone mineral density

Nguyen, L.T.H.; Luong, K.V.Q., 2004:
Levothyroxine-induced hyperthyroidism

Martin, M.H.; Ames, M.D., 2000:
Lewis Charles Frost

Kerr, C.L.; Hanna, W.; Shaper, J.H.; Wright, W.W., 2000:
Lewis X-containing neoglycoproteins bind to zona pellucida receptors on murine sperm

Sauter, G.; Himmler, G.; Loibner, H., 2003:
Lewis Y/EpCAM co-expression in breast cancer is correlated with poor prognosis

Fitchette, A.C.therine; Cabanes Macheteau, M.; Gomord, V.; Lerouge, P.; Faye, L.; Martin, B.; Hawes, C., 2000:
Lewis a-containing N-glycans are localized in the Golgi apparatus and at the surface of plant cells

Li, C.J.n; Keh, C.C.K.; Varma, R.S.; Namboodiri, V.V., 2002:
Lewis acid catalyzed formation of tetrahydropyrans in ionic liquid

Saez, J.A.; Arno, M.; Domingo, L.R., 2003:
Lewis acid-catalyzed cycloaddition of 2- acrolein with furan Insight on the nature of the mechanism from a DFT analysis

Larock, R.C.; Hanson, M., 2001:
Lewis acid-catalyzed polymerization of biological oils and resulting polymeric materials

Rauniyar, V.; Hall, D.G., 2004:
Lewis acids catalyze the addition of allylboronates to aldehydes by electrophilic activation of the dioxaborolane in a closed transition structure

Wheeler, R.A.; Wheeler, D.S.; Grigson, P.S., 2001:
Lewis and Fischer 344 rats exhibit different responses to cocaine and morphine in the saccharin avoidance design

Haile, C.N.; Kosten, T.A., 2000:
Lewis and Fischer rats show differential effects of D1- and D2-like compounds on cocaine self-administration

Vestergaard, E.M.; Hein, H.O.; Meyer, H.W.H.; Grunnet, N.; Jorgensen, J.; Wolf, H.; Orntoft, T.F., 1999:
Lewis and secretor genotype-based reference values for tumor marker CA 19-9 and evaluation of secretor and Lewis genotyping in a Caucasian population

Hynes, S.O.; Moran, A.P., 2000:
Lewis antigen expression on outer membrane vesicles of Helicobacter pylori Implications for virulence

Sheu, B.S.; Yang, H.B.; Shiesh, S.C.; Chuang, C.H.; Wu, J.J., 2000:
Lewis antigen phenotype is a significant host factor relevant to Helicobacter pylori infection of the dyspeptic patients in Taiwan

Rasko, D.A.; Keelan, M.; Thomson, A.B.; Taylor, D.E., 2000:
Lewis antigen phenotype is altered in Helicobacter pylori isolated from asymptomatic subjects

Keelan, M.; Rasko, D.; Taylor, D.E., 2000:
Lewis antigen phenotype is altered in Helicobacter pylori isolated from gastric aspirates vs antral biopsies of asymptomatic subjects

Nogueira, A.M.F.; Marques, T.; Soares, P.; Queiroz, D.; Rocha, G.; Rocha, A.; Santos, A.; David, L.; Reis, C., 2002:
Lewis expression in childrens gastric mucosa Relationship with Helicobacter pylori infection and cagA status

Michopoulos, S.; Tsibouris, P.; Katopi, D.; Sotiropoulou, M.; Giotopoulou, V.; Balta, A.; Galanopoulos, G.; Kralios, N., 2000:
Lewis phenotype influences ulcerative colitis extent

Pouget, J.; Verschueren, A.; Azulay, J.P.ilippe; Attarian, S., 2001:
Lewis-Sumner syndrome and multifocal motor neuropathy with conduction block One single entity?

Lepper, P.M.; Laub, J.; Moericke, A.; Trautmann, M., 2002:
Lewis-type antigens in clinical Helicobacter pylori isolates

Zheng, P.Y.; Ng, H.C.; Hua, J.; Ho, B., 2000:
Lewisb expression in Helicobacter pylori does not interfere with the bacterial adhesion property in vitro

Kehe, K.; Schneider, J.; Bartling, A.; Reichl, F.X.; Kreppel, H.; Szinicz, L., 2003:
Lewisite induces apoptosis in HaCaT-cells independent from caspase activation

Sugiyama, H.; Kashihara, N.; Yamasaki, Y.; Sekikawa, T.; Makino, H., 2000:
Lewis(y) expression and renal tubular atrophy in IgA nephritis

Saito, Y.; Ruberu, N.N.; Sawabe, M.; Hiroshi, Y.; Murayama, S., 2003:
Lewy - related alpha - synucleinopathy in aging human brain

Lippa, C.F.; Schmidt, M.L.; Lee, V.M.Y.; Trojanowski, J.Q., 2001:
Lewy bodies in familial Alzheimers disease alpha-Synuclein epitope mapping parallels dementia with Lewy bodies and Parkinsons disease, but differs from multisystem atrophy

Popescu, A.; Lippa, C.F., 2001:
Lewy bodies in the amygdala alpha-Synuclein expression is increased in specific neurodegenerative diseases

Riley, David E., 2002:
Lewy body disease

Leverenz, J.B.; Bonner, L.T.; Tsuang, D.W.; Nochlin, D.; Peskind, E.R.; Kraybill, M.; Bowen, J.D.; Mccormick, W.C.; Teri, L.; Raskind, M.A.; Kukull, W.A.; Larson, E., 2003:
Lewy body pathology in community- and research-based samples of Alzheimers disease Frequency and risk factors

Wakisaka, Y.; Furuta, A.; Tanizaki, Y.; Kiyohara, Y.; IIda, M.; Iwaki, T., 2002:
Lewy body pathology in consecutive autopsies of a certain community based population

Kovari, E.; Gold, G.; Giannakopoulos, P.; Lovero, P.; Surini, M.; Bouras, C., 2000:
Lewy body pathology in different neurodegenerative diseases

Leverenz, J.B.; Tsuang, D.W.; Fishel, M.A.; Steinbart, E.; Raskind, M.A.; Nochlin, D.; Schellenberg, G.D.; Bird, T.D., 2003:
Lewy body pathology in familial Alzheimers disease A clinical-neuropathological study in ethnic Volga Germans with a PS-2 mutation or APOE epsilon4

Santacruz, K.; Pahwa, R.; Lyons, K.; Troster, A.; Handler, M.; Koller, W.; Decarli, C., 1999:
Lewy body, neurofibrillary tangle and senile plaque pathology in Parkinsons disease patients with and without dementia

Goto, Y.; Hashizume, Y.; Yoshida, M.; Konagaya, M.; Sobue, G., 2000:
Lewy-related dystrophic neurites in cerebral cortex of Parkinsons disease and diffuse Lewy body disease

Pellicano, S.; Calzone, R.; Bertuccio, A.; Ranieri, S.F.; Rombola, F.; Del Giudice, A.C.; Bertuccio, S.N., 2004:
Lewys bodies dementia - A case report

Arnott, W.L.; Chenery, H.J., 1999:
Lexical decision in Parkinsons disease A comment on Spicer, Brown, and Gorell , and McDonald, Brown, and Gorell

Ozawa, K.; Fiorentino, R.; Poeppel, D., 2003:
Lexical frequency and the M350 MEG response

Brown, T.T.; Lugar, H.M.; Coalson, R.S.; Miezin, F.M.; Petersen, S.E.; Schlaggar, B.L., 2002:
Lexical processing growing up how brain regions showing age related effects for controlled lexical tasks change across maturation

Asato, K.M.; Tsai, I.M.; Mcdaniel, M.R., 2003:
Lexicon development of appearance and texture descriptors for melted cheddar cheese

Hayakawa,F.; Ukai,N.; Nishida,J.; Kazami,Y.; Kohyama,K., 2010:
Lexicon for the sensory description of French bread in Japan

Kuhn, S.P.; Amos, A.E.; Haldeman, M.T.; Liu, C., 2002:
Lexicon-enhanced text searching for biological information in the CAS databases

D.T.nno, F.; Tavolini, I.M.; Bertoldin, R.; Curti, P.; Belmonte, P.B.; Fandella, A.; Guaitoli, P.; Cossaro, E.; D'inca, G.; Guazzieri, S., 2003:
Leydig Cell Tumours of the testis The GUONE experience

Kaponis, A.J.; Kanakas, N.; Mio, Y.; Miyagawa, I.; Sofikitis, N., 2003:
Leydig and sertoli cell secretory function in men with Y-chromosome microdeletions

Luo, L.D.; Chen, H.; Kim, J.M.n; Ghosh, R.; Zirkin, B.R., 2002:
Leydig cell aging Cyclic AMP, StAR, and the steroidogenic enzymes

Luo, L.; Chen, H.; Zirkin, B.R., 2000:
Leydig cell aging Steroidogenic acute regulatory protein and cholesterol side-chain cleavage enzyme

Dong, Q.; Hardy, M.P., 2004:
Leydig cell function in man

Williams, D.H.I.; Grayhack, J.T.; Stellmach, V.; Crawford, S.E.; Case, J.; Lee, C.; Brannigan, R.E., 2004:
Leydig cell hyperplasia and increased microvascular density in pigment epithelium-derived factor null mice testes

Seber, A.; Antoneli, Célia.Beatriz.Gianotti.; Spinola-Castro, A.Maria.; Oyafuso, M.Suheko., 2002:
Leydig cell tumor and mature teratoma: unusual non-ocular tumors associated with sexual pseudo-precocity six years after unilateral retinoblastoma

Jain, T.; VanKessel, K.; Reed, S.; Paley, P., 2000:
Leydig cell tumor, mature teratoma, and nongestational choriocarcinoma in a single ovary

Rich, M.A.; Keating, M.A., 2000:
Leydig cell tumors and tumors associated with congenital adrenal hyperplasia

D.T.nno, F.; Tavolini, I.M.tteo; Fandella, A.; Bertoldin, R.; Curti, P.; Belmonte, P.; Cossaro, E.; Guaitoli, P.; Guazzieri, S.; D'inca, G., 2003:
Leydig cell tumors of the testis Experience about 50 cases from the GUONE

Fallick, M.L.; Lin, W.W.; Lipshultz, L.I., 1999:
Leydig cell tumors presenting as azoospermia

Mooney, E.E.; Man, Y.G.; Bratthauer, G.L.; Tavassoli, F.A., 1999:
Leydig cells in Sertoli-Leydig cell tumors have a reactive rather than a neoplastic molecular profile

Liu, G.; Duranteau, L.; Carel, J.C.; Monroe, J.; Doyle, D.A.; Shenker, A., 1999:
Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor

Bakal, C.J.; Wu, C.; Finan, D.; Rottapel, R.K., 2002:
Lfc, a RhoGEF, is required for proper chromosome segregation during mitosis

Tao, T.; Lan, J.; Sweezey, N.B.; Kaplan, F., 2002:
Lgl2, a novel importin beta family protein, supports the nuclear relocation of the glucocorticoid receptor

Obray, J.B.; Long, T.R.; Brown, M.J.; Wass, C.Thomas., 2003:
Lhermitte sign associated with postdural puncture headache in a parturient

Demaerel, P.; Van Calenbergh, F.; Wilms, G., 2003:
Lhermitte-Duclos disease: a tumour or not a tumour

Reuss, A.E.; Wray, S., 2002:
Lhrh neurons express phospholipid transfer protein

Failli, V.; Rogard, M.; Besson, M.J.; Retaux, S., 2000:
Lhx9 LIM-homeodomain factor Genomic structure and expression patterns of alternatively spliced isoforms in the developing brain

Failli, V.; Pere, S.; Lledo, P.M.; Bach, I.; Retaux, S., 2001:
Lhx9alpha, a truncated LIM homeodomain factor, inhibits neuronal differentiation of PC12 cells

Li, D.K.n; Janevic, T.; Odouli, R.; Liu, L., 2003:
Li et al respond to No link between hot tubs and miscarriage

Los, G.V.; Hokin, L.E., 1999:
Li+ increases high affinity sodium-dependent glutamate uptake in human neuroblastoma cells

Abukhdeir, A.M.; Layden, B.T.; Minadeo, N.; D.F.eitas, D.M.ta, 2002:
Li+/Mg2+ competition during chronic treatment with therapeutic Li+ levels in human neuroblastoma SH-SY5Y cells

D.F.eitas, D.M.ta; Williams, N.; Geraldes, C.F.G.C., 2003:
Li+/Mg2+ competition for Mg2+-binding sites in G-proteins Implications for bipolar disorder

Layden, B.; D.F.eitas, D.E.M.ta, 2000:
Li+/Mg2+ competition in human lymphoblastoma cells

Minadeo, N.M.; Amari, L.; D.F.eitas, D.E.M.ta, 2000:
Li+Mg+2 competition and binding site determination in recombinant Gia1

Wong, B.W.; Fan, S.T.; Luk, J.M., 2003:
Li-cadherin , a potential biomarker for hepatocellular carcinoma

Garofalo, R.S.; Orena, S.J.; Torchia, A.J., 1999:
LiCl stimulates glycogen synthase and glucose transport via distinct mechanisms in 3T3-L1 adipocytes

Jin, E.J.ng; Thibaudeau, G., 1999:
LiCl-induced phosphoprotein involved in pigment development in the embryonic zebrafish

Kasai,M.; Ikeda,M.; Asahina,T.; Fujisawa,K., 2010:
LiDAR-derived DEM evaluation of deep-seated landslides in a steep and rocky region of Japan

Ponjee, G.A.E.; Van Doorn, L.J.; Stet, E.; Quint, W.G.V., 2000:
LiPA Factor V Leiden/FII mutant

Bhananker, S.M.; Posner, K.L.; Domino, K.B.; Lee, L.; Cheney, F.W., 2003:
Liability Associated with Monitored Anesthesia Care ASA Closed Claims Project

Long, J.C.; Reed, S.; Robin, R.W.; Goldman, D., 2001:
Liability distribution for alcohol dependence in a Southwestern American Indian tribe

Shete, S.S.; Amos, C.I., 2001:
Liability groups in linkage analysis

Kershen, Drew L., 2003:
Liability issues related to transgene flow in agriculture

Juriloff, D.M.; Harris, M.J.; Gunn, T.M.; Wu, M.K.; Mah, D.G.; Dewell, S.L., 2001:
Liability loci for multifactorial cleft lip and palate map to the same chromosomal locations as liability loci for multifactorial neural tube closure defects in mice

Vanyukov, M.M.; Tarter, R.E.; Kirisci, L.; Kirillova, G.P.; Maher, B.S.; Clark, D.B., 2003:
Liability to substance use disorders: 1. Common mechanisms and manifestations

Vanyukov, M.M.; Kirisci, L.; Tarter, R.E.; Simkevitz, H.F.; Kirillova, G.P.; Maher, B.S.; Clark, D.B., 2003:
Liability to substance use disorders: 2. A measurement approach

Kanda, K.; Sato, S.; Kemuriyama, T., 2000:
Liability to temporal summation of the flexor reflex in aged rats

Koenig, B.; Ivankovic, B.; Schleff, R.; Mack, M., 1999:
Liaison free PSA-an automated chemiluminescent immunoassay for the determination of free prostate specific antigen

Forbes, R.; Craig, J.; Callender, M.; Patterson, V., 2004:
Liaison neurology for acute medical admissions

Pignatello, M.A.; Kauffman, F.C.; Levin, A.A., 2002:
Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures A model to explain the potency of the aromatic retinoid -4- -1-propenyl benzoic acid

Taverne, Louis, 2004:
Libanechelys bultyncki gen et sp nov, a new primitive eel from the marine Cenomanian of Lebanon

Joedicke, R.; Van Tol, J., 2003:
Libellula aenea Linnaeus, 1758 and L flavomaculata Vander Linden, 1825 Proposed conservation of usage of the specific names by the replacement of the lectotype of L aenea with a newly designated lectotype

Bolt, Hermann A., 2004:
Liber testimonii

Fok,M.; XuNaiYin, 2010:
Liberalization and regulation of varieties and seed markets in China Bt-cotton case study

Bhorade, S.M.; Jordan, A.M.; Vigneswaran, W.T.; Garrity, E.R., 2003:
Liberalization of donor criteria does not compromise outcomes three years after lung transplantation

Donini, A.; Baccarani, U.; Lavaroni, S.; Dialti, V.; Adami, V.; Risaliti, A.; Cautero, N.; Degrassi, A.; Bresadola, F., 2001:
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation

Hahn, W.E.; Arnold, C.A., 2002:
Liberating intracellular matter from biological material

Foust, G.N.; Potter, W.A., 2000:
Liberation from mechanical ventilation Efficacy of readiness testing via a two step pressure support breathing challenge with noninvasive positive pressure ventilation as a contingency plan

Neubert, R.H.H.; Pötzsch, A., 2004:
Liberation of hydrocortisone acetate from different commercial formulations

Aizenman, E.; Pal, S.; Hartnett, K.; Nerbonne, J.M.; Levitan, E.S., 2003:
Liberation of intracellular zinc in neuronal apoptosis Role of KV21-encoded potassium channels

Everett, S.A.; Stratford, M.R.L.; Patel, K.B.; Naylor, M.A.; Murray, G.I.; Wardman, P., 2000:
Liberation of nitric oxide from stable pro-drugs by cytochrome P450 mono-oxygenases expressed in tumours

Kikugawa, K.; Hiramoto, K., 2001:
Liberation of reactive nitrogen oxide species from N-nitrosamine by ultraviolet light irradiation

Hsu, Eric, 2004:
Liberty Hyde Bailey Pioneer of palm systematics

Damann, K.E.; Tubajija, K.M., 2002:
Liberty TM herbicide reduces aflatoxin contamination in corn

Kridli, R.T.; Shaker, M.M.mani; Abdullah, A.Y.; Sada, I., 2002:
Libido and biological parameters of mature Awassi, Awassi x Charollais and Awassi x Romanov rams

Wyllie, M.G., 2003:
Libido and desire: join the club?

Santos, M.D.; Torres, C.A.A.; Guimaraes, J.D.; Ruas, J.R.M.; Carvalho, G.R., 2003:
Libido of nellore bulls Effect of bull Cow ratio on pregnancy rate

Gelgand, E.A.; Sibbitt, W.G.; Roldan, C.A., 2003:
Libman-Sacks vegetations are associated with cerebrovascular disease in patients with systemic lupus erythematosus

Boldi, A.M., 2004:
Libraries from natural product-like scaffolds

Berube, M.; Ciobanu, L.C.; Poirier, D., 2001:
Libraries of 16beta-estradiol derivatives as inhibitors of steroid sulfatase and type 1 17beta-hydroxysteroid dehydrogenase

Gilon, C.; Hornik, V., 2000:
Libraries of backbone-cyclized peptidomimetics

Gao, J.; Strässler, C.; Tahmassebi, D.; Kool, E.T., 2002:
Libraries of composite polyfluors built from fluorescent deoxyribosides

Southern, E.M.llor; Shchepinov, M.S.rgeevich; Housby, J.N.cholas; Hamilton, A.L.wis; Elder, J.K.nneth, 2004:
Libraries of oligomers labeled with different tags

Szostak, J.W.; Roberts, R.W.; Liu, R., 2001:
Libraries of protein encoding RNA-protein fusions

Sud, M.; Hebert, N.; Sage, C., 2002:
Library design R-group ranking for favorable ADME characteristics

Poupon, E.; Duval, R.; Lewin, G.; Hocquemiller, R., 2003:
Library of squamocin analogs by click chemistry

Ichikawa, E.; Platts Mills, T.A.E.; Wheatley, L.M., 1999:
Library screening and recombinant expression A new approach to the question of allergic response to bacterial proteins

Treco, D.A.; Miller, A.M., 1999:
Library screening method

Schmuttenmaer, C.; Venables, D.S.; Huang, K., 2002:
Librational motion of water confined within reverse micelles and in proteins

Lonetto, Michael Arthur, 2001:
LicC

Lonetto, Michael Arthur, 2001:
LicD1 polypeptides

Lafuente, M.; Roca, V.; Martin Mateo, M.P.; Carbonell, E.; Estrada, A., 2000:
Lice and ticks parasitizing Audouins gull Larus audouinii Payraudeau, 1826 in the Chafarinas Islands

Altschuler, Deborah Z., 2003:
Lice comb cleaning device

Kiel, J.S.; Ping, J.H., 2002:
Lice removing composition

Caplan, L.R., 2000:
Lice, fleas, and strokes

Frank, S.; Ebert, A.D., 2001:
License to kill tumors: how much hope is justified for trail?

Lygerou, Z.; Nurse, P., 2000:
License withheld Geminin blocks DNA replication

Mehta, J.M., 2001:
Licensing IP to ensure accessibility to vaccines and other immunisation-related products

Good, A.M.; Strachan, F.; Oliver, J.J.; Kelly, C.A.; Bateman, D.N., 2002:
Licensing decisions and TOXBASE Evaluating the effect of restricted indications for thioridazine on its use in acute overdose

Takisawa, Haruhiko, 2001:
Licensing of DNA replication in the proliferation of eukaryotic cells

Miller, C.E.; Baty, B.; Berkheim, L.; Cantwell, M.; Dent, K.; Mcdonald, J.; Mensching, L.; Palumbos, J.; Pho, L.; Solomon, C.; Venne, V.; Hafen, B.; Rosenthal, E.; Poss, A., 2001:
Licensure of genetic counselors Success in Utah

Arosio, G.; Pozzoli, M.L.isa; Scarselli, S., 2002:
Lichen Biodiversity in the surroundings of a Thermo-Electric Power Station in the province of Lodi

Seaward, M.R.D., 2003:
Lichen Herbarium at The Manchester Museum 1 Collectors

Isocrono, D.; Matteucci, E.; Allisiardi, C.; Piervittori, R., 2003:
Lichen biodiversity in the Maritime Alps studies on substrate specificity in the Valasco Valley

Scerbo, R.; Possenti, L.; Lampugnani, L.; Ristori, T.; Barale, R.; Barghigiani, C., 1999:
Lichen biomonitoring of trace element contamination and air quality assessment in Livorno Province

Scerbo, R.; Ristori, T.; Possenti, L.; Lampugnani, L.; Barale, R.; Barghigiani, C., 2002:
Lichen biomonitoring of trace element contamination and air quality assessment in Pisa Province

Coxson, D.S.; Marsh, J., 2001:
Lichen chronosequences in lodgepole pine forests of northern interior British Columbia

Caniglia, G.M.ria; Grillo, M., 2001:
Lichen colonization on the archeological area of Megara Iblea

Will Wolf, Susan, 2002:
Lichen community indicators of old-growth characteristics in western Great Lakes managed forests

Burmeister, M.S.; Deline, C.S.; Greenwood Deline, L.; Kimmey, J.A.; Schrage, K.M.; Wachholder, B.E.; Meiners, S.J.; Methven, A.S., 2003:
Lichen community structure on gravestones A preliminary investigation

Mccutcheon, D.E., 2001:
Lichen flora of county Durham Supplement 1

Seaward, M.R.D.; Henderson, A., 1999:
Lichen flora of the West Yorkshire conurbation Supplement VI

Trenbirth,H.E.; Matthews,J.A., 2010:
Lichen growth rates on glacier forelands in southern Norway preliminary results from a 25-year monitoring programme

D.Vries, Bernard, 2003:
Lichen inventory of the Crooked Lake Fen Nature Sanctuary

Lo, P.Y.; Tzung, T.Y., 2000:
Lichen myxedematosus in a patient with hepatocellular carcinoma

Panda, S.; Malakar, S., 2003:
Lichen nitidus-like allergic contact dermatitis - a clinicopathological study

Metin, A.; Calka, O.; Ugras, S., 2001:
Lichen planopilaris coexisting with erythema dyschromicum perstans

Gross, S.A.; Katz, S.; Garofalo, J.A.; Anhalt, G.J., 2003:
Lichen planus esophagitis mimicking intractable erosive esophagitis

Daramola, O.O.M.; Ogunbiyi, A.O.; George, A.O., 2002:
Lichen planus following hepatitis B vaccination in an African girl

Ukleja, A.; Achem, S.R., 2000:
Lichen planus of the esophagus mimicking peptic stricture

Baran, R., 2000:
Lichen planus of the nails mimicking the yellow nail syndrome

Sangvichien, E.; Homchantara, N.; Mongkolsuk, P.; Boonprakob, K., 2000:
Lichen research in Thailand

Hunger, R.E.; Yawalkar, N.; Kappeler, A.; Mueller, C.; Braathen, L.R., 2004:
Lichen sclerosus Detection of activated cytotoxic cells in the cellular infiltrates

Barbagli, G.; Palminteri, E.; Vallesciani, S.; Lazzeri, M.; Turini, D., 2004:
Lichen sclerosus and penile carcinoma

Barbagli, G.; Palminteri, E., 1999:
Lichen sclerosus involving anterior urethra

Crow, J.C.; Rolfe, K.J.; Levine, T.S.; Reid, W.; Maclean, A.B.; Perrett, C.W., 2000:
Lichen sclerosus, squamous hyperplasia and differentiated VIN A pathway to vulval malignancy

Yashar, S.; Han, K.F.; Haley, J.C., 2004:
Lichen sclerosus-lichen planus overlap in a patient with hepatitis C virus infection

Sorgentini, C.; Allevato, M.A.; Dahbar, M.; Cabrera, H., 2004:
Lichen striatus in an adult: successful treatment with tacrolimus

Hansen, E.S., 2001:
Lichen-rich soil crusts of arctic Greenland

Li, X.L.ang; Ljungdahl, L.G.; Chen, H., 2000:
Lichenase and coding sequences

Kocourkova, Jana, 2000:
Lichenicolous fungi of the Czech Republic

Ooi, B.C.; Phua, K.B.; Lee, B.L.; Tan, C.E.; Ng, I.S.; Quak, S.H., 2001:
Lichenification and enlargement of hands and feet: a sign of progressive familial intrahepatic cholestasis with normal gamma-glutamyl-transpeptidase

Ooi, B.C.; Phua, K.B.; Tan, V.C.C., 2000:
Lichenification and hypertrophy of hands and feet A characteristic sign of Byler disease

Magro, C.M.; Pilavdzic, D.; Crowson, A.N., 1999:
Lichenoid and granulomatous dermatitis A novel cutaneous reaction pattern

Canonne-Courivaud, D.; Carpentier, O.; Dejobert, Y.; Hachulla, E.; Delaporte, E., 2003:
Lichenoid drug reaction to leflunomide

Lim, D.; Muir, J., 2002:
Lichenoid eruption to STI 571

Horiuchi, Y., 2001:
Lichenoid eruptions due to ursodeoxycholic acid administration

Corazza, M.; Zampino, M.Rosaria.; Montanari, A.; Pagnoni, A.; Virgili, A., 2002:
Lichenoid reaction from a permanent red tattoo: has nickel a possible aetiologic role?

Rubegni, P.; Fimiani, M.; de Aloe, G.; Andreassi, L., 2000:
Lichenoid reaction to temporary tattoo